Home | Overview of gut regions | Anatomy | Histology | Transgene expression mapping | Gene expression |
Mean expression enrichment by gut region
Filter out everything which GO terms when the expression scale ratio is comprised between -1.5 and 1.5 for all regions |
GO term | Number of genes | Crop / Full gut |
R2 / Full gut |
R3 / Full gut |
R4 / Full gut |
R5 / Full gut |
Hindgut / Full gut |
Cardia/R1 / Full gut |
---|---|---|---|---|---|---|---|---|
protein deneddylation | 3 | 1.57 | -1.01 | 1.18 | 1.14 | 1.14 | 1.07 | -1.1 |
stress fiber | 1 | 1.76 | 1.07 | 1.13 | 1.08 | 1.49 | 1.28 | 1.15 |
glycoprotein binding | 1 | 3.21 | -1.21 | 1.67 | 1.12 | 1.32 | 6.4 | 2.23 |
lymphocyte mediated immunity | 2 | -2.37 | 1.1 | 1.16 | -1.04 | 1.34 | -1.89 | 1.24 |
renal sodium ion transport | 1 | -52.82 | -1.7 | -31.49 | 1.13 | -9.63 | 16.55 | -13.85 |
ferrochelatase activity | 1 | 1.62 | 1.26 | 1.09 | -1.07 | 1.01 | 1.21 | 1.32 |
nicotinamidase activity | 1 | -2.04 | 1.72 | -1.29 | 1.07 | 1.25 | 4.26 | 2.23 |
lipoate biosynthetic process | 2 | 1.65 | 1.07 | 1.42 | 1.08 | 1.12 | 2.67 | -1.13 |
response to UV-B | 1 | 1.85 | -1.14 | 1.04 | 1.61 | 1.1 | 1.04 | 1.04 |
ectodermal cell differentiation | 2 | 4.98 | -1.19 | 1.75 | -1.46 | 1.16 | 1.31 | 1.35 |
nuclear matrix | 3 | -1.0 | 1.28 | 1.38 | 1.16 | 1.24 | 1.52 | 1.32 |
ceramidase activity | 2 | -7.56 | -2.15 | -1.17 | 1.28 | -1.14 | -15.17 | -6.93 |
acyl-CoA delta11-desaturase activity | 1 | -3.53 | -3.34 | -2.71 | -4.29 | -3.06 | -2.31 | 4.71 |
cytokine binding | 3 | 1.17 | 1.12 | 1.1 | 1.02 | 1.54 | 1.2 | 1.72 |
T-tubule | 1 | 1.33 | 1.32 | 2.26 | 1.11 | 1.52 | 1.39 | 1.48 |
A band | 9 | 1.95 | -1.09 | -1.15 | -1.11 | 1.13 | 1.79 | 1.07 |
cleavage furrow | 9 | -1.04 | 1.09 | 1.57 | 1.01 | 1.45 | 1.33 | 1.15 |
ESCRT-0 complex | 2 | -1.75 | 1.13 | 2.24 | 1.06 | 1.39 | 1.34 | 1.26 |
ribosome localization | 1 | 2.15 | -1.01 | 1.44 | 1.25 | 1.44 | 1.28 | 1.21 |
protein localization in Golgi apparatus | 10 | -1.16 | 1.12 | 1.17 | 1.04 | 1.21 | 1.41 | 1.65 |
pupation | 4 | 2.01 | -1.05 | 1.24 | -1.24 | 1.14 | 2.15 | 1.25 |
DNA dealkylation | 1 | 1.12 | -1.01 | 1.19 | 1.74 | 1.2 | 1.06 | -1.09 |
AP-2 adaptor complex binding | 1 | 1.51 | 1.33 | 2.01 | 1.25 | 1.81 | 2.91 | 1.9 |
DNA protection | 1 | 1.02 | -1.01 | 1.31 | 1.02 | 1.58 | 1.3 | 1.2 |
presynaptic membrane | 8 | -1.25 | 1.03 | 1.27 | -1.02 | 1.34 | 1.8 | 1.18 |
main axon | 2 | -1.07 | -1.38 | -1.02 | -1.09 | 1.18 | 3.54 | 1.59 |
actin nucleation | 4 | -2.38 | 1.35 | 1.23 | 1.09 | 1.22 | -1.94 | 1.21 |
negative regulation of S phase of mitotic cell cycle | 11 | 1.34 | 1.21 | 1.41 | 1.15 | 1.44 | 1.65 | 1.53 |
habituation | 4 | 1.3 | -1.01 | 1.62 | 1.18 | 1.4 | 1.83 | 1.26 |
actin crosslink formation | 1 | 2.2 | 1.13 | -1.01 | 1.18 | 1.16 | -1.08 | 1.17 |
glycolipid binding | 1 | -2.99 | 1.35 | -1.24 | 1.41 | -1.1 | -2.55 | -1.06 |
catecholamine transport | 2 | 3.07 | -1.44 | -1.47 | -1.28 | -1.45 | -1.2 | -1.42 |
carboxylic ester hydrolase activity | 99 | -1.69 | -1.12 | -1.47 | -1.07 | -1.31 | -2.03 | -1.33 |
foraging behavior | 1 | -12.04 | -1.69 | 9.34 | -2.59 | -11.09 | -12.8 | -6.11 |
regulation of canonical Wnt receptor signaling pathway | 6 | 1.19 | 1.08 | 1.68 | 1.07 | 1.07 | 1.06 | 1.46 |
establishment of blood-brain barrier | 19 | 2.5 | -1.26 | 1.24 | -1.17 | 1.21 | 2.3 | 1.4 |
Wnt protein secretion | 1 | 1.86 | -1.05 | 2.03 | 1.04 | 1.26 | 2.03 | 1.19 |
RISC-loading complex | 1 | 1.44 | 1.23 | 1.89 | 1.19 | 2.25 | 1.64 | 1.56 |
cellular response to ecdysone | 11 | 1.32 | 1.19 | 1.43 | 1.13 | 1.47 | 1.53 | 1.33 |
regulation of ion homeostasis | 3 | 1.14 | 1.14 | 1.39 | 1.16 | 1.04 | 1.71 | 1.47 |
protein thiol-disulfide exchange | 1 | -1.26 | 1.49 | 1.56 | 1.08 | 1.23 | -1.31 | 1.33 |
alpha-1,6-mannosyltransferase activity | 1 | 1.2 | 1.3 | 1.28 | 1.05 | 1.27 | 1.14 | 1.6 |
trans-hexaprenyltranstransferase activity | 2 | 2.38 | 1.18 | 1.12 | 1.03 | 1.43 | 1.86 | 1.15 |
phosphopyruvate hydratase complex | 1 | 1.97 | 1.06 | -1.39 | -1.17 | -1.32 | 2.59 | 1.17 |
alpha-glucoside transport | 2 | 1.24 | -2.16 | -1.19 | -2.0 | -1.13 | 3.38 | 1.3 |
regulation of DNA recombination | 2 | -1.59 | 1.15 | 1.13 | 1.19 | 1.42 | -1.74 | -1.31 |
regulation of mitotic recombination | 1 | -2.02 | 1.1 | 1.06 | 1.2 | 1.9 | -2.66 | -1.77 |
negative regulation of mitotic recombination | 1 | -2.02 | 1.1 | 1.06 | 1.2 | 1.9 | -2.66 | -1.77 |
alpha-1,2-mannosyltransferase activity | 1 | -1.58 | 1.15 | -1.08 | 1.11 | -1.2 | -1.77 | 1.49 |
acyl carrier activity | 6 | 1.59 | 1.03 | 1.12 | 1.01 | 1.14 | 1.4 | 1.17 |
very long-chain fatty acid metabolic process | 5 | 3.63 | -2.39 | -2.2 | -3.1 | -1.91 | -1.08 | 3.71 |
long-chain fatty acid transporter activity | 7 | -2.15 | 1.3 | -1.32 | -1.52 | -2.35 | -1.39 | -1.5 |
protein targeting to Golgi | 10 | -1.16 | 1.12 | 1.17 | 1.04 | 1.21 | 1.41 | 1.65 |
autophagic vacuole fusion | 2 | 1.14 | 1.16 | 1.85 | 1.13 | 1.26 | 1.5 | 1.09 |
urea cycle | 1 | -31.89 | 1.77 | -20.72 | 1.41 | 1.0 | -12.66 | -3.5 |
argininosuccinate metabolic process | 1 | -31.89 | 1.77 | -20.72 | 1.41 | 1.0 | -12.66 | -3.5 |
ribosomal subunit export from nucleus | 1 | 2.15 | -1.01 | 1.44 | 1.25 | 1.44 | 1.28 | 1.21 |
ribosomal large subunit export from nucleus | 1 | 2.15 | -1.01 | 1.44 | 1.25 | 1.44 | 1.28 | 1.21 |
protein import into nucleus, docking | 2 | -1.85 | 1.21 | 1.23 | 1.37 | 1.53 | -1.37 | -1.23 |
protein import into nucleus, translocation | 2 | 1.98 | -1.11 | 1.05 | 1.22 | 1.33 | 2.03 | -1.05 |
fatty-acyl-CoA binding | 8 | -2.25 | -1.27 | -1.85 | 1.18 | 1.35 | -2.52 | -1.44 |
L-ornithine transmembrane transporter activity | 1 | 1.32 | 1.45 | -1.5 | 1.71 | 1.05 | 1.03 | -1.1 |
mitochondrial ornithine transport | 1 | 1.32 | 1.45 | -1.5 | 1.71 | 1.05 | 1.03 | -1.1 |
M phase specific microtubule process | 1 | 1.59 | 1.65 | -1.13 | 1.13 | 1.0 | -1.46 | -1.04 |
G1 phase of mitotic cell cycle | 1 | -1.2 | 1.72 | 1.55 | 1.31 | 1.53 | 1.21 | 1.72 |
G1/S transition of mitotic cell cycle | 14 | 1.35 | 1.24 | 1.43 | 1.21 | 1.54 | 1.24 | 1.25 |
regulation of transcription involved in G1/S phase of mitotic cell cycle | 1 | 1.31 | 1.43 | 1.45 | 1.16 | 1.14 | 1.54 | 1.46 |
G2 phase of mitotic cell cycle | 1 | 1.67 | 1.26 | 1.32 | 1.4 | 1.23 | 1.13 | 1.21 |
mitotic anaphase B | 2 | 1.04 | 1.25 | 1.4 | 1.16 | 1.52 | -1.16 | 1.12 |
mitotic telophase | 1 | 1.4 | 1.02 | 1.15 | 1.14 | 1.72 | -1.18 | -1.16 |
sulfur amino acid biosynthetic process | 3 | 1.32 | 1.11 | 1.04 | -1.09 | -1.92 | 1.19 | 1.3 |
sulfur amino acid transmembrane transporter activity | 1 | -7.18 | -1.45 | -9.47 | 1.62 | 3.49 | -2.41 | -5.84 |
sulfur amino acid transport | 1 | -7.18 | -1.45 | -9.47 | 1.62 | 3.49 | -2.41 | -5.84 |
sulfate assimilation | 1 | -2.63 | 1.06 | 1.41 | 1.07 | 1.11 | -1.64 | -1.02 |
nucleotide-excision repair complex | 3 | 1.73 | 1.2 | 1.21 | 1.15 | 1.32 | 1.1 | -1.16 |
regulation of transcription involved in G2/M-phase of mitotic cell cycle | 1 | 1.12 | 1.4 | 1.69 | -1.0 | 1.67 | 1.7 | 1.71 |
transcription factor TFIIIB complex | 2 | 1.19 | 1.29 | 1.5 | 1.13 | 1.51 | 1.31 | 1.18 |
establishment of mitotic spindle orientation | 2 | 1.02 | 1.4 | 1.82 | 1.21 | 1.49 | 1.4 | 1.34 |
Golgi cis cisterna | 1 | -1.12 | 1.19 | 1.36 | 1.12 | 1.23 | -1.28 | 1.74 |
Golgi trans cisterna | 2 | -1.03 | 1.16 | 1.1 | 1.38 | 1.81 | 1.12 | 1.1 |
microfilament motor activity | 3 | 6.28 | -1.75 | 1.12 | -1.66 | 1.09 | 3.74 | -1.21 |
cytoplasmic ubiquitin ligase complex | 1 | 2.69 | 1.18 | 1.72 | 1.15 | -1.01 | -1.18 | -1.08 |
rRNA modification | 5 | 1.57 | 1.18 | 1.26 | 1.33 | 1.41 | 1.18 | -1.02 |
two-component sensor activity | 3 | 1.12 | -1.13 | 1.03 | -1.08 | 1.69 | 1.52 | -1.14 |
two-component response regulator activity | 1 | -1.1 | 1.39 | 1.36 | 1.05 | 1.38 | 3.53 | 1.68 |
protein phosphatase type 2A complex | 8 | 1.09 | 1.04 | 1.37 | 1.07 | 1.23 | 2.15 | 1.1 |
two-component signal transduction system (phosphorelay) | 3 | -1.1 | 1.14 | 1.08 | -1.02 | -1.02 | 1.53 | 1.01 |
protein phosphatase type 1 complex | 5 | 1.43 | 1.05 | 1.28 | 1.01 | 1.16 | 1.5 | 1.4 |
ribonuclease MRP complex | 1 | 1.84 | 1.03 | 1.1 | 1.42 | 1.17 | 1.05 | -1.14 |
rRNA (adenine-N6,N6-)-dimethyltransferase activity | 2 | 1.61 | 1.27 | 1.44 | 1.22 | 1.57 | 1.46 | 1.13 |
rDNA binding | 2 | -1.04 | 1.15 | 1.82 | 1.29 | 2.02 | 1.26 | 1.15 |
activation of MAPK activity | 7 | 1.11 | 1.21 | 1.54 | 1.12 | 1.37 | 2.0 | 1.14 |
inactivation of MAPK activity | 1 | 2.84 | 1.44 | 1.69 | 1.19 | 1.68 | 4.37 | 1.83 |
MAPK import into nucleus | 1 | 1.14 | 1.19 | 1.6 | 1.04 | 1.48 | 1.45 | 1.57 |
protein ubiquitination involved in ubiquitin-dependent protein catabolic process | 5 | 1.02 | 1.13 | 2.15 | 1.07 | 1.56 | 1.16 | 1.11 |
vacuolar proton-transporting V-type ATPase, V0 domain | 13 | -2.32 | -1.03 | 1.35 | -1.29 | -1.38 | 1.02 | -1.29 |
vacuolar proton-transporting V-type ATPase, V1 domain | 12 | -1.17 | 1.02 | 1.44 | -1.12 | -1.04 | 1.8 | -1.01 |
peptide-N4-(N-acetyl-beta-glucosaminyl)asparagine amidase activity | 1 | -1.09 | 1.27 | 1.39 | 1.28 | 1.54 | -1.1 | 1.18 |
cytoplasmic chromosome | 1 | 1.18 | 1.16 | 1.75 | 1.38 | 1.68 | 1.06 | -1.24 |
mitotic prometaphase | 1 | -1.39 | -1.16 | -1.07 | 1.34 | 1.62 | -1.16 | -1.17 |
C-4 methylsterol oxidase activity | 2 | -1.31 | -6.89 | -7.44 | -1.07 | -3.2 | -1.65 | -1.68 |
allantoin metabolic process | 2 | 3.32 | -1.45 | -1.35 | -1.39 | -1.17 | 1.29 | -1.34 |
allantoin catabolic process | 1 | 2.85 | -1.01 | 1.16 | 1.03 | -1.08 | 1.74 | -1.1 |
sodium:amino acid symporter activity | 5 | 1.26 | 1.14 | -2.06 | -1.96 | -1.76 | -1.26 | 1.36 |
nucleoside transmembrane transporter activity | 6 | -1.51 | 1.3 | -1.37 | 1.14 | -1.09 | -1.36 | -1.05 |
proton-transporting ATPase activity, rotational mechanism | 21 | 1.15 | -1.01 | 1.22 | -1.1 | -1.03 | 1.64 | -1.08 |
mitochondrial chromosome | 1 | 1.18 | 1.16 | 1.75 | 1.38 | 1.68 | 1.06 | -1.24 |
mitochondrial fission | 2 | 1.47 | -1.03 | 1.65 | 1.15 | 1.07 | 1.58 | -1.11 |
peptidoglycan metabolic process | 12 | -1.13 | -1.64 | -1.19 | -1.04 | -1.82 | -1.69 | -1.29 |
polysaccharide biosynthetic process | 22 | 1.55 | 1.02 | -1.01 | 1.03 | 1.12 | 1.58 | 1.25 |
polysaccharide catabolic process | 30 | -1.17 | -1.91 | -2.09 | -1.67 | -1.68 | -1.04 | 1.4 |
mitochondrial proton-transporting ATP synthase complex, catalytic core F(1) | 8 | 1.58 | -1.08 | 1.12 | -1.1 | 1.01 | 1.92 | -1.31 |
mitochondrial proton-transporting ATP synthase complex, coupling factor F(o) | 9 | 1.19 | 1.04 | 1.31 | 1.01 | 1.22 | 1.62 | -1.14 |
1-phosphatidylinositol-3-phosphate 5-kinase activity | 1 | -1.33 | 1.29 | 1.91 | 1.33 | 2.36 | 1.28 | 1.16 |
nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay | 10 | 1.48 | 1.17 | 1.74 | 1.19 | 1.61 | 1.9 | 1.56 |
nuclear-transcribed mRNA poly(A) tail shortening | 7 | 1.62 | 1.13 | 1.74 | 1.15 | 1.59 | 2.05 | 1.42 |
deadenylation-dependent decapping of nuclear-transcribed mRNA | 2 | 1.27 | 1.29 | 1.78 | 1.53 | 1.51 | 1.59 | 1.46 |
nuclear-transcribed mRNA catabolic process, exonucleolytic | 1 | -1.45 | 1.76 | 1.14 | 1.42 | 1.29 | -1.3 | 1.32 |
integral to membrane of membrane fraction | 2 | 1.74 | 1.04 | 1.6 | 1.07 | 1.43 | 2.77 | 1.46 |
retrograde transport, vesicle recycling within Golgi | 10 | -1.16 | 1.12 | 1.17 | 1.04 | 1.21 | 1.41 | 1.65 |
response to superoxide | 2 | 1.69 | 1.17 | 1.01 | 1.09 | 1.11 | 1.41 | -1.08 |
response to oxygen radical | 2 | 1.69 | 1.17 | 1.01 | 1.09 | 1.11 | 1.41 | -1.08 |
nicotinamide-nucleotide adenylyltransferase activity | 1 | -2.52 | 1.99 | 1.32 | 1.32 | 1.09 | -1.34 | 1.43 |
organellar ribosome | 72 | 1.04 | 1.07 | 1.23 | 1.29 | 1.25 | 1.45 | -1.55 |
organellar large ribosomal subunit | 44 | 1.03 | 1.05 | 1.24 | 1.3 | 1.28 | 1.46 | -1.6 |
protein-methionine-R-oxide reductase activity | 1 | 2.04 | 1.02 | -1.15 | -1.19 | -1.3 | 1.08 | -1.25 |
lytic vacuole | 28 | -2.58 | -1.1 | -2.35 | 1.15 | -1.08 | -2.06 | -3.03 |
alternative nuclear mRNA splicing, via spliceosome | 1 | 1.52 | 1.27 | 1.61 | 1.3 | 1.51 | 2.77 | 1.58 |
spliceosomal complex disassembly | 1 | 1.69 | 1.29 | 1.56 | 1.32 | 1.6 | 1.63 | 1.44 |
RNA splicing, via endonucleolytic cleavage and ligation | 3 | 1.93 | 1.15 | 1.42 | 1.2 | 1.36 | 1.44 | 1.34 |
four-way junction DNA binding | 1 | -1.12 | 1.35 | 2.36 | 1.33 | 2.9 | 1.28 | 1.43 |
mitochondrion degradation | 1 | 2.65 | 1.08 | 1.15 | 1.38 | 1.25 | 2.74 | 1.17 |
maturation of 2S rRNA | 1 | 1.7 | -1.05 | -1.07 | -1.09 | -1.18 | 1.33 | 1.14 |
oxidized base lesion DNA N-glycosylase activity | 3 | 2.16 | -1.01 | 1.16 | 1.13 | 1.13 | 1.51 | -1.03 |
oxidized pyrimidine base lesion DNA N-glycosylase activity | 1 | 3.75 | 1.0 | 1.19 | 1.14 | 1.11 | 1.95 | 1.06 |
meiotic mismatch repair | 1 | 1.34 | 1.15 | 1.36 | 1.37 | 1.61 | 1.16 | 1.18 |
nucleotide-excision repair, DNA damage recognition | 1 | 1.35 | 1.22 | 1.6 | 1.15 | 1.67 | 2.6 | 1.56 |
DNA catabolic process, endonucleolytic | 4 | 1.64 | 1.12 | 1.39 | 1.15 | 1.35 | 1.4 | 1.54 |
DNA catabolic process, exonucleolytic | 2 | -1.31 | 1.21 | 1.11 | 1.22 | 1.62 | -1.59 | -1.29 |
nuclear chromosome, telomeric region | 2 | 1.89 | 1.01 | 1.39 | 1.11 | 1.79 | 1.05 | 1.11 |
X chromosome | 6 | 1.37 | 1.23 | 1.41 | 1.11 | 1.23 | 1.51 | 1.37 |
GINS complex | 2 | 1.77 | 1.11 | 1.3 | 1.14 | 1.18 | 1.14 | -1.06 |
inositol-1,4,5-trisphosphate 6-kinase activity | 1 | -1.15 | 1.56 | -1.07 | 1.07 | -1.15 | -1.25 | 1.09 |
inositol hexakisphosphate kinase activity | 1 | -1.38 | 1.16 | 2.02 | -1.07 | 2.12 | 1.33 | 1.59 |
translation repressor activity, nucleic acid binding | 6 | 1.94 | 1.04 | 2.03 | 1.04 | 1.61 | 1.46 | 1.82 |
gamma-tubulin complex | 8 | 1.55 | 1.01 | 1.26 | 1.07 | 1.31 | 1.48 | 1.15 |
gamma-tubulin large complex | 5 | 1.67 | -1.04 | 1.23 | 1.09 | 1.31 | 1.41 | 1.1 |
cytoplasmic mRNA processing body | 13 | 1.31 | 1.27 | 1.6 | 1.18 | 1.51 | 1.59 | 1.3 |
mitochondrial RNA metabolic process | 3 | 1.29 | 1.23 | 1.41 | 1.12 | 1.47 | 1.73 | -1.1 |
RNA polymerase II core promoter proximal region sequence-specific DNA binding | 4 | 1.25 | 1.09 | 1.19 | 1.0 | 1.33 | 1.57 | 1.45 |
RNA polymerase II basal transcription factor binding transcription factor activity | 6 | 1.58 | 1.1 | 1.46 | 1.16 | 1.41 | 1.29 | 1.2 |
TFIIA-class transcription factor binding | 3 | 1.34 | 1.29 | 1.39 | 1.2 | 1.61 | 1.37 | 1.28 |
TFIIF-class transcription factor binding | 2 | 1.1 | 1.32 | 1.52 | 1.2 | 1.24 | 1.14 | 1.45 |
RNA polymerase II activating transcription factor binding | 4 | 2.11 | -1.73 | -1.85 | -1.26 | -1.03 | 1.44 | 1.34 |
RNA polymerase II transcription coactivator activity | 8 | 1.57 | -1.19 | -1.01 | 1.03 | 1.27 | 1.49 | 1.13 |
RNA polymerase II transcription corepressor activity | 2 | 1.12 | 1.2 | 1.26 | 1.29 | 1.7 | 1.19 | 1.25 |
RNA polymerase II transcription coactivator activity involved in preinitiation complex assembly | 2 | 1.66 | -1.04 | 1.36 | 1.21 | 1.19 | 1.16 | -1.0 |
TBP-class protein binding RNA polymerase II transcription factor activity involved in preinitiation complex assembly | 6 | 1.58 | 1.1 | 1.46 | 1.16 | 1.41 | 1.29 | 1.2 |
TBP-class protein binding RNA polymerase II transcription factor activity | 6 | 1.58 | 1.1 | 1.46 | 1.16 | 1.41 | 1.29 | 1.2 |
DNA-dependent transcriptional start site selection | 1 | 2.19 | 1.23 | -1.08 | 1.33 | 1.17 | -1.1 | 1.1 |
transcriptional start site selection at RNA polymerase II promoter | 1 | 2.19 | 1.23 | -1.08 | 1.33 | 1.17 | -1.1 | 1.1 |
RNA polymerase II transcription factor binding transcription factor activity involved in positive regulation of transcription | 8 | 1.57 | -1.19 | -1.01 | 1.03 | 1.27 | 1.49 | 1.13 |
entry into host | 2 | 1.04 | 1.05 | 1.19 | -1.29 | -1.39 | 2.64 | 1.17 |
neurotransmitter uptake | 1 | -1.06 | -1.11 | -1.0 | -1.08 | -1.15 | 3.37 | -1.04 |
acetylcholine catabolic process in synaptic cleft | 1 | 2.27 | 1.23 | -5.17 | -1.59 | -2.2 | -9.9 | 9.42 |
regulation of action potential | 8 | 1.57 | -1.04 | 1.3 | -1.12 | 1.17 | 2.65 | 1.29 |
RNA methylation | 10 | 1.62 | 1.18 | 1.23 | 1.26 | 1.35 | 1.29 | 1.02 |
selenocysteine incorporation | 1 | 1.74 | 1.02 | 1.02 | 1.41 | 1.48 | -1.49 | -1.06 |
peptide amidation | 1 | 2.74 | 1.3 | 1.75 | 1.08 | 1.98 | 1.97 | 2.28 |
lipopolysaccharide binding | 1 | 8.83 | -1.7 | -1.73 | -1.63 | -1.34 | 3.89 | 1.3 |
ovarian follicle development | 1 | -1.49 | 2.58 | -1.26 | -1.23 | -1.23 | -1.38 | 1.24 |
oocyte growth | 2 | 1.25 | 1.36 | 1.54 | 1.22 | 1.6 | 1.07 | 1.72 |
regulation of cell growth | 38 | 1.09 | 1.19 | 1.46 | 1.1 | 1.43 | 1.53 | 1.25 |
galactoside binding | 2 | 1.45 | -1.07 | 1.88 | 1.03 | 1.06 | 1.31 | 1.14 |
detection of chemical stimulus involved in sensory perception of bitter taste | 1 | -1.77 | -1.51 | -1.46 | -1.66 | 9.03 | 1.38 | -1.43 |
detection of chemical stimulus involved in sensory perception of sweet taste | 1 | 15.43 | 1.05 | -1.1 | -1.34 | 2.06 | 11.73 | 3.15 |
dense fibrillar component | 1 | -1.19 | 1.16 | -1.05 | 1.68 | 1.27 | -1.6 | -1.28 |
conditioned taste aversion | 3 | 1.58 | 1.48 | 1.62 | -1.13 | 1.26 | 1.28 | 1.57 |
ameboidal cell migration | 35 | 1.62 | -1.01 | 1.31 | -1.06 | 1.21 | 1.46 | 1.11 |
acrosomal vesicle | 1 | -1.22 | 1.14 | 1.06 | 1.01 | -1.52 | -1.37 | 1.04 |
ATPase activator activity | 3 | 1.77 | 1.07 | 1.2 | 1.24 | 1.37 | 1.32 | 1.35 |
long-chain fatty acid metabolic process | 8 | 2.31 | -2.32 | -1.73 | -1.98 | -1.14 | -1.49 | 1.69 |
histamine metabolic process | 2 | 1.02 | -1.27 | 1.33 | 1.09 | 1.3 | 1.8 | 1.14 |
histamine biosynthetic process | 1 | -1.31 | -1.76 | 1.72 | 1.22 | 1.97 | 3.11 | 1.28 |
formation of primary germ layer | 28 | 1.53 | -1.01 | 1.18 | -1.09 | 1.11 | 1.67 | 1.15 |
ectoderm formation | 2 | 4.98 | -1.19 | 1.75 | -1.46 | 1.16 | 1.31 | 1.35 |
endoderm formation | 4 | 2.13 | -1.15 | 1.08 | -1.19 | 1.07 | 2.11 | 1.76 |
mesoderm formation | 26 | 1.41 | 1.01 | 1.15 | -1.07 | 1.1 | 1.6 | 1.11 |
endodermal cell fate commitment | 1 | 8.12 | -1.58 | 1.44 | -1.54 | 1.01 | 1.69 | 1.21 |
ectodermal cell fate commitment | 2 | 4.98 | -1.19 | 1.75 | -1.46 | 1.16 | 1.31 | 1.35 |
ectodermal cell fate specification | 2 | 4.98 | -1.19 | 1.75 | -1.46 | 1.16 | 1.31 | 1.35 |
ruffle | 2 | 1.28 | 1.39 | 2.24 | -1.02 | 2.03 | 1.81 | 1.72 |
lipid kinase activity | 2 | 1.57 | 1.08 | 1.68 | -1.01 | 1.59 | 1.77 | 1.96 |
ceramide kinase activity | 1 | 2.79 | -1.02 | 1.66 | -1.11 | 1.24 | 2.25 | 2.21 |
establishment of imaginal disc-derived wing hair orientation | 22 | 1.56 | 1.08 | 1.28 | 1.02 | 1.4 | 1.32 | 1.3 |
neuron migration | 1 | -1.42 | 1.01 | 1.2 | 1.29 | 2.44 | -1.59 | 1.35 |
kidney development | 3 | -1.1 | -1.05 | -1.04 | -1.15 | -1.04 | 1.01 | 1.54 |
pattern binding | 116 | -1.88 | -1.54 | -1.66 | -1.39 | -1.53 | -1.88 | 1.19 |
response to yeast | 1 | 5.18 | -1.34 | 1.33 | -1.5 | 1.33 | 6.7 | 1.77 |
nucleoside binding | 5 | -2.97 | 1.34 | -1.45 | 1.07 | -1.17 | -2.3 | -1.24 |
endothelial cell development | 3 | 1.7 | 1.01 | 1.41 | -1.21 | 1.32 | 4.52 | 2.14 |
selenium compound metabolic process | 2 | 1.76 | 1.25 | 1.23 | 1.04 | 1.04 | 1.62 | -1.07 |
tissue homeostasis | 20 | 1.33 | -1.02 | 1.13 | -1.12 | 1.22 | 1.46 | 1.54 |
negative regulation of protein phosphorylation | 2 | -1.04 | 1.11 | 1.79 | -1.0 | 1.29 | 1.24 | 1.01 |
positive regulation of protein phosphorylation | 5 | 1.08 | 1.17 | 1.78 | 1.11 | 1.35 | 1.9 | 1.34 |
regulation of cell-matrix adhesion | 2 | 1.91 | 1.0 | 2.08 | 1.07 | 1.96 | 1.63 | 1.31 |
negative regulation of cell-matrix adhesion | 1 | 2.96 | 1.13 | 1.75 | -1.2 | 1.98 | 1.94 | 1.75 |
startle response | 13 | 1.09 | 1.15 | 1.46 | 1.07 | 1.52 | 1.19 | 1.26 |
G-protein alpha-subunit binding | 2 | -1.16 | 1.18 | -1.02 | 1.16 | 1.01 | -1.6 | -1.07 |
morphogenesis of an epithelial sheet | 1 | 1.57 | 1.36 | 1.53 | 1.09 | 1.59 | 1.28 | 1.35 |
regulation of heart rate | 3 | -2.33 | 1.98 | 1.4 | -1.73 | -1.39 | 2.29 | -1.17 |
p53 binding | 1 | 1.78 | 1.16 | 2.67 | 1.12 | 2.53 | 3.19 | 2.15 |
epithelial cell development | 14 | 1.16 | 1.1 | 1.33 | 1.01 | 1.23 | 1.71 | 1.39 |
protein depalmitoylation | 2 | 2.75 | 1.12 | 1.29 | 1.19 | 1.61 | 1.16 | 1.22 |
regulation of receptor internalization | 2 | 2.64 | -1.34 | 1.04 | -1.28 | -1.11 | 2.63 | 1.36 |
positive regulation of receptor internalization | 2 | 2.64 | -1.34 | 1.04 | -1.28 | -1.11 | 2.63 | 1.36 |
polyprenyltransferase activity | 1 | 1.04 | 1.26 | 1.1 | 1.28 | -1.02 | -1.97 | -1.12 |
tRNA wobble base modification | 2 | 1.94 | 1.19 | 1.23 | 1.17 | 1.27 | 1.92 | 1.12 |
tRNA wobble uridine modification | 2 | 1.94 | 1.19 | 1.23 | 1.17 | 1.27 | 1.92 | 1.12 |
podosome | 1 | -1.23 | -1.76 | -1.82 | -1.76 | -2.16 | 17.9 | -1.88 |
store-operated calcium entry | 1 | 2.66 | -1.14 | 1.6 | 1.07 | 1.44 | 4.2 | 2.14 |
aggressive behavior | 44 | 1.19 | 1.05 | 1.23 | -1.02 | 1.15 | 1.61 | 1.24 |
inter-male aggressive behavior | 42 | 1.18 | 1.06 | 1.2 | 1.0 | 1.15 | 1.58 | 1.25 |
G-quadruplex RNA binding | 1 | 1.1 | 1.52 | 1.31 | 1.18 | 1.34 | 1.42 | 1.38 |
palmitoyltransferase complex | 1 | -1.92 | 1.11 | 2.34 | 1.27 | 1.64 | -1.44 | -1.26 |
defense response to insect | 1 | 23.01 | -3.14 | -2.9 | -3.17 | -2.48 | 1.73 | 2.58 |
positive regulation of antimicrobial peptide production | 1 | -1.72 | 1.19 | -1.18 | 1.31 | 1.64 | 3.16 | 1.11 |
innate immune response in mucosa | 1 | -1.37 | -1.13 | -1.19 | -1.54 | 1.82 | 7.35 | 2.8 |
response to molecule of bacterial origin | 3 | 2.15 | 1.03 | 1.06 | -1.04 | 1.33 | 1.63 | 1.06 |
adaptive immune response | 2 | -2.37 | 1.1 | 1.16 | -1.04 | 1.34 | -1.89 | 1.24 |
organ or tissue specific immune response | 7 | 1.24 | 1.06 | 1.29 | -1.06 | 1.56 | 1.62 | 1.43 |
immune effector process | 20 | 1.79 | -1.15 | 1.28 | -1.11 | 1.26 | 1.41 | 1.26 |
activation of immune response | 1 | 1.17 | 1.46 | 1.63 | 1.36 | 1.42 | 1.78 | 1.19 |
myeloid leukocyte activation | 1 | 2.18 | -2.11 | 2.19 | 1.49 | 1.48 | 1.37 | 1.38 |
mucosal immune response | 7 | 1.24 | 1.06 | 1.29 | -1.06 | 1.56 | 1.62 | 1.43 |
immune response-regulating cell surface receptor signaling pathway involved in phagocytosis | 3 | 1.28 | -1.17 | 2.05 | 1.18 | 1.64 | 1.24 | 1.18 |
inflammatory response to antigenic stimulus | 2 | -2.37 | 1.1 | 1.16 | -1.04 | 1.34 | -1.89 | 1.24 |
acute inflammatory response to antigenic stimulus | 2 | -2.37 | 1.1 | 1.16 | -1.04 | 1.34 | -1.89 | 1.24 |
production of molecular mediator of immune response | 2 | -1.54 | 1.11 | 1.81 | 1.12 | 1.7 | 3.17 | 1.43 |
leukocyte mediated immunity | 2 | -2.37 | 1.1 | 1.16 | -1.04 | 1.34 | -1.89 | 1.24 |
adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 2 | -2.37 | 1.1 | 1.16 | -1.04 | 1.34 | -1.89 | 1.24 |
hypersensitivity | 2 | -2.37 | 1.1 | 1.16 | -1.04 | 1.34 | -1.89 | 1.24 |
positive regulation of immune system process | 8 | 1.43 | 1.03 | 1.15 | 1.01 | 1.19 | 1.8 | 1.48 |
positive regulation of immune effector process | 1 | -1.72 | 1.19 | -1.18 | 1.31 | 1.64 | 3.16 | 1.11 |
positive regulation of production of molecular mediator of immune response | 1 | -1.72 | 1.19 | -1.18 | 1.31 | 1.64 | 3.16 | 1.11 |
antimicrobial peptide production | 2 | -1.54 | 1.11 | 1.81 | 1.12 | 1.7 | 3.17 | 1.43 |
antifungal peptide production | 1 | -1.72 | 1.19 | -1.18 | 1.31 | 1.64 | 3.16 | 1.11 |
regulation of antifungal peptide production | 7 | 2.0 | -1.32 | -1.17 | 1.03 | 1.03 | 1.92 | 1.18 |
peptide secretion | 1 | 1.36 | -1.09 | 1.47 | 1.03 | 1.67 | -1.23 | 2.47 |
positive regulation of antifungal peptide production | 1 | -1.72 | 1.19 | -1.18 | 1.31 | 1.64 | 3.16 | 1.11 |
negative regulation of antimicrobial peptide biosynthetic process | 2 | 1.03 | 1.14 | 1.57 | 1.07 | 1.57 | -1.03 | -1.32 |
positive regulation of antimicrobial peptide biosynthetic process | 23 | 1.75 | -1.22 | -1.09 | -1.11 | -1.01 | 1.39 | 1.29 |
negative regulation of antibacterial peptide biosynthetic process | 2 | 1.03 | 1.14 | 1.57 | 1.07 | 1.57 | -1.03 | -1.32 |
regulation of antifungal peptide biosynthetic process | 6 | 2.45 | -1.42 | -1.16 | -1.01 | -1.05 | 1.77 | 1.2 |
regulation of biosynthetic process of antibacterial peptides active against Gram-negative bacteria | 7 | 1.96 | -1.11 | 1.11 | -1.19 | 1.09 | 1.65 | 1.22 |
negative regulation of biosynthetic process of antibacterial peptides active against Gram-negative bacteria | 2 | 1.03 | 1.14 | 1.57 | 1.07 | 1.57 | -1.03 | -1.32 |
regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria | 4 | 1.05 | -1.9 | -2.24 | -1.85 | -1.9 | -1.18 | 1.68 |
negative regulation of response to biotic stimulus | 7 | 1.37 | 1.0 | 1.62 | 1.21 | 1.38 | -1.12 | -1.13 |
positive regulation of response to biotic stimulus | 1 | 8.35 | -1.25 | -1.3 | -1.07 | -1.15 | 1.62 | -1.07 |
negative regulation of humoral immune response | 4 | 1.35 | 1.1 | 1.46 | 1.15 | 1.8 | 1.12 | 1.2 |
skeletal muscle contraction | 2 | -1.89 | -1.52 | -1.42 | -1.43 | -1.62 | -1.61 | 2.67 |
renal system process | 6 | -4.46 | 1.18 | -1.92 | -1.14 | -3.52 | -1.44 | -1.93 |
negative regulation of heart induction by canonical Wnt receptor signaling pathway | 3 | 1.09 | 1.1 | 1.13 | 1.08 | 1.18 | 1.14 | 2.09 |
outflow tract morphogenesis | 3 | -1.03 | 1.08 | 1.55 | 1.17 | 2.15 | 1.03 | 1.48 |
regulation of organ formation | 8 | 1.56 | -1.2 | -1.1 | 1.04 | 1.14 | 1.2 | -1.02 |
endothelium development | 3 | 1.7 | 1.01 | 1.41 | -1.21 | 1.32 | 4.52 | 2.14 |
Wnt receptor signaling pathway involved in heart development | 3 | 1.09 | 1.1 | 1.13 | 1.08 | 1.18 | 1.14 | 2.09 |
amino acid transmembrane transport | 30 | -1.61 | -1.12 | -1.51 | -1.16 | -1.02 | -1.08 | -1.1 |
apical constriction | 4 | -1.26 | 1.28 | 1.59 | 1.06 | 1.39 | 1.15 | 1.23 |
cytoneme morphogenesis | 2 | -1.85 | -1.12 | 1.68 | 1.29 | 1.66 | 1.71 | -2.53 |
neural retina development | 1 | -1.1 | -1.15 | -1.07 | -1.18 | 1.52 | 1.28 | 1.24 |
bent DNA binding | 2 | 1.7 | 1.14 | 1.37 | 1.1 | 1.36 | 1.18 | 1.22 |
lamin binding | 1 | 1.4 | 1.14 | 1.18 | 1.58 | 1.38 | 1.2 | 1.19 |
satellite DNA binding | 5 | 1.25 | 1.13 | 1.51 | 1.21 | 1.5 | 1.17 | 1.18 |
termination of RNA polymerase II transcription | 1 | -1.51 | -1.02 | 1.38 | 1.04 | 1.42 | 1.11 | -1.1 |
cytoplasmic sequestering of transcription factor | 4 | 2.74 | 1.08 | 1.33 | 1.02 | 1.2 | 2.19 | 1.75 |
double-stranded RNA binding | 16 | 1.33 | -1.04 | 1.19 | -1.13 | 1.16 | 1.42 | 1.51 |
double-stranded RNA adenosine deaminase activity | 1 | 1.13 | 1.14 | 1.55 | 1.01 | 1.4 | 2.0 | 1.26 |
mRNA 3'-UTR binding | 17 | 1.34 | 1.14 | 1.46 | 1.02 | 1.31 | 1.89 | 1.29 |
response to unfolded protein | 2 | 1.04 | 1.38 | 1.16 | -1.1 | 1.05 | 1.03 | 1.56 |
contractile fiber | 33 | 2.45 | -1.47 | -1.08 | -1.25 | 1.2 | 1.97 | -1.14 |
actin filament bundle assembly | 17 | 1.57 | -1.02 | 1.24 | -1.1 | 1.24 | 1.29 | 1.51 |
barbed-end actin filament capping | 2 | -1.38 | -1.03 | 2.18 | 1.01 | 1.59 | -1.39 | -1.04 |
actin monomer binding | 1 | -3.23 | -1.14 | 1.86 | -1.09 | 2.26 | -4.44 | -1.1 |
acute-phase response | 1 | 1.84 | 1.22 | 1.59 | 1.61 | 1.65 | 1.41 | 1.04 |
lysozyme activity | 14 | 1.98 | -1.64 | -2.07 | -1.66 | -1.61 | -1.16 | 1.06 |
defense response to fungus | 28 | 1.68 | -1.27 | -1.31 | -1.29 | -1.25 | 1.08 | 1.24 |
response to virus | 12 | 2.35 | -1.64 | -1.09 | -1.61 | 1.07 | 1.84 | 1.26 |
serine-type endopeptidase activity | 263 | -2.24 | -1.42 | -1.67 | -1.14 | -1.46 | -2.32 | -1.65 |
protein-glutamine gamma-glutamyltransferase activity | 2 | 5.84 | -1.94 | -1.03 | -1.59 | -1.03 | 2.32 | 1.28 |
antigen binding | 1 | -1.71 | -1.18 | -1.3 | -1.15 | -1.23 | -1.3 | 1.07 |
alpha,alpha-trehalose-phosphate synthase (UDP-forming) activity | 1 | 1.32 | -4.96 | -6.02 | -4.98 | -1.62 | 7.64 | -3.94 |
alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity | 1 | 3.18 | 1.02 | 1.47 | 1.11 | 1.44 | 4.09 | 2.36 |
beta-1,4-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity | 1 | 3.39 | -1.12 | 1.06 | -1.11 | 1.06 | 1.27 | -1.12 |
beta-alanyl-dopamine hydrolase activity | 1 | -1.31 | -1.76 | 1.72 | 1.22 | 1.97 | 3.11 | 1.28 |
beta-ureidopropionase activity | 1 | 17.28 | -3.07 | -1.83 | -2.92 | -2.4 | 3.32 | 1.6 |
gamma-glutamyltransferase activity | 4 | 1.24 | -1.34 | -1.15 | 1.08 | 1.94 | 1.31 | -1.06 |
1-acylglycerol-3-phosphate O-acyltransferase activity | 6 | -1.56 | -1.19 | -1.0 | 1.18 | 2.24 | -2.62 | -1.99 |
1-pyrroline-5-carboxylate dehydrogenase activity | 3 | 1.56 | -1.48 | -1.15 | -1.62 | -1.43 | 2.14 | 1.15 |
1,3-beta-D-glucan synthase activity | 1 | 12.72 | -1.88 | -1.16 | -3.3 | -1.54 | 3.13 | 2.87 |
1,4-alpha-glucan branching enzyme activity | 1 | 3.55 | -1.35 | -1.97 | 1.08 | 1.09 | 1.58 | 1.19 |
1-alkyl-2-acetylglycerophosphocholine esterase activity | 1 | 3.85 | 1.07 | 1.8 | 1.09 | 1.57 | 2.16 | 1.8 |
2-hydroxyacylsphingosine 1-beta-galactosyltransferase activity | 5 | -4.34 | 1.01 | 1.27 | 1.24 | 1.5 | -3.41 | -1.26 |
3-beta-hydroxy-delta5-steroid dehydrogenase activity | 1 | 7.52 | -1.63 | -1.52 | -1.44 | -1.48 | 2.76 | 1.78 |
3-hydroxyisobutyryl-CoA hydrolase activity | 1 | 1.35 | 1.24 | 1.18 | -1.16 | -1.11 | 6.95 | -1.22 |
3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity | 2 | 1.67 | 1.29 | 1.69 | -1.02 | 1.34 | 1.99 | 1.11 |
3-oxo-5-alpha-steroid 4-dehydrogenase activity | 1 | -1.31 | 1.28 | -1.32 | 1.3 | 1.08 | -2.32 | -1.18 |
4-aminobutyrate transaminase activity | 1 | -1.88 | 3.07 | -1.92 | -1.52 | -1.3 | -2.05 | 1.06 |
4-hydroxyphenylpyruvate dioxygenase activity | 1 | 1.86 | -1.07 | 1.21 | 1.03 | 1.14 | 1.09 | -1.06 |
5-aminolevulinate synthase activity | 1 | 1.58 | 1.36 | -1.31 | -1.09 | -1.26 | 1.25 | 1.23 |
6-phosphofructokinase activity | 1 | 2.63 | -1.22 | -1.22 | 1.02 | -1.12 | 5.11 | 1.3 |
6-phosphofructo-2-kinase activity | 1 | 1.09 | -1.34 | 2.59 | -1.04 | 1.14 | 3.38 | -1.06 |
6-pyruvoyltetrahydropterin synthase activity | 1 | 2.12 | 1.31 | 1.32 | 1.23 | 1.73 | 1.01 | 2.0 |
AMP deaminase activity | 1 | 1.21 | 1.11 | 1.3 | -1.14 | 1.24 | 3.4 | 1.06 |
protein C-terminal carboxyl O-methyltransferase activity | 1 | -2.13 | 1.18 | 1.09 | 1.41 | 1.8 | -1.71 | -1.76 |
CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity | 1 | 2.1 | -1.04 | 1.71 | -1.1 | 1.9 | -1.29 | 1.13 |
CDP-diacylglycerol-serine O-phosphatidyltransferase activity | 1 | 1.61 | 1.37 | 2.22 | 1.0 | 1.13 | 1.67 | 1.83 |
D-amino-acid oxidase activity | 2 | -2.82 | -1.69 | -2.22 | 1.7 | 1.95 | -1.63 | -1.83 |
DNA-(apurinic or apyrimidinic site) lyase activity | 5 | 1.72 | -1.0 | 1.07 | 1.11 | 1.19 | 1.32 | 1.0 |
methylated-DNA-[protein]-cysteine S-methyltransferase activity | 1 | 1.12 | -1.01 | 1.19 | 1.74 | 1.2 | 1.06 | -1.09 |
DNA ligase (ATP) activity | 2 | 1.29 | 1.46 | 1.49 | 1.24 | 1.5 | 1.27 | 1.28 |
DNA topoisomerase (ATP-hydrolyzing) activity | 3 | -1.26 | 1.43 | 1.56 | 1.29 | 1.52 | 1.12 | 1.27 |
GMP synthase activity | 1 | 1.14 | 1.09 | 1.34 | -1.05 | 1.24 | 1.35 | 2.12 |
GMP synthase (glutamine-hydrolyzing) activity | 1 | 1.14 | 1.09 | 1.34 | -1.05 | 1.24 | 1.35 | 2.12 |
GPI-anchor transamidase activity | 1 | 1.21 | 1.1 | 1.8 | 1.25 | 1.66 | -1.16 | 1.35 |
synaptic vesicle uncoating | 2 | -1.44 | 1.22 | 1.71 | 1.06 | 1.91 | 1.53 | 1.42 |
GTP cyclohydrolase activity | 1 | 33.5 | -5.63 | -5.79 | -6.03 | -4.58 | -1.32 | 6.94 |
GTP cyclohydrolase I activity | 1 | 33.5 | -5.63 | -5.79 | -6.03 | -4.58 | -1.32 | 6.94 |
hydrogen ion transporting ATP synthase activity, rotational mechanism | 16 | 1.35 | -1.04 | 1.11 | -1.09 | -1.01 | 1.54 | -1.13 |
IMP cyclohydrolase activity | 1 | -1.39 | 1.0 | -1.49 | -1.01 | -1.06 | 1.63 | -1.09 |
IMP dehydrogenase activity | 1 | 1.16 | 1.34 | 1.12 | 1.03 | 1.08 | -1.1 | 1.99 |
L-iditol 2-dehydrogenase activity | 3 | 1.17 | -1.39 | -1.37 | 1.12 | 1.23 | 1.74 | -1.02 |
L-iduronidase activity | 1 | -1.71 | 1.0 | 1.11 | -1.04 | 1.62 | -1.12 | -1.27 |
N-acetylgalactosamine-4-sulfatase activity | 4 | 1.55 | -1.16 | -1.4 | 1.09 | 1.42 | 2.61 | -1.17 |
NAD+ ADP-ribosyltransferase activity | 1 | -2.18 | 1.38 | 1.41 | 1.1 | 1.13 | -1.47 | 1.05 |
NAD+ synthase (glutamine-hydrolyzing) activity | 1 | 2.07 | 1.6 | 1.04 | 1.19 | 1.4 | 2.13 | 1.77 |
NADH dehydrogenase activity | 36 | 1.13 | 1.03 | 1.27 | 1.06 | 1.1 | 1.72 | -1.29 |
NADPH-hemoprotein reductase activity | 1 | 1.63 | 1.35 | 1.12 | -1.0 | 1.2 | -1.04 | 1.34 |
NADPH dehydrogenase activity | 1 | -1.51 | 1.45 | 1.08 | 1.06 | -1.12 | -1.58 | -1.42 |
RNA-directed DNA polymerase activity | 1 | 1.54 | 1.82 | 1.92 | -1.04 | 1.87 | 1.15 | 2.39 |
UDP-N-acetylglucosamine diphosphorylase activity | 1 | -1.57 | -1.13 | 1.65 | -1.09 | 1.26 | -1.83 | 1.72 |
UDP-glucose:glycoprotein glucosyltransferase activity | 1 | 1.21 | 1.16 | 1.35 | -1.04 | 1.59 | 1.69 | 2.54 |
acetate-CoA ligase activity | 2 | 1.63 | 1.11 | -1.36 | -1.04 | -1.71 | 1.16 | 1.18 |
acetyl-CoA C-acyltransferase activity | 4 | 1.58 | 1.11 | -1.25 | 1.12 | 1.08 | 1.06 | -1.32 |
acetyl-CoA carboxylase activity | 1 | 7.73 | 1.2 | -1.41 | -2.71 | 1.2 | 3.14 | 4.69 |
acetylcholinesterase activity | 1 | 2.27 | 1.23 | -5.17 | -1.59 | -2.2 | -9.9 | 9.42 |
acid phosphatase activity | 12 | 1.44 | 1.13 | -1.05 | -1.03 | -1.02 | 1.81 | 1.28 |
aconitate hydratase activity | 4 | 1.11 | 1.25 | 1.22 | -1.14 | -1.03 | 1.75 | 1.32 |
acyl-CoA dehydrogenase activity | 15 | -1.17 | 1.11 | -1.37 | 1.1 | 1.1 | -1.79 | -1.3 |
acyl-CoA oxidase activity | 6 | -2.19 | 1.03 | -1.7 | 1.08 | 1.14 | -3.66 | -1.47 |
acylphosphatase activity | 6 | 1.57 | 1.0 | -1.02 | 1.01 | -1.1 | 1.04 | -1.12 |
adenosine deaminase activity | 8 | -1.69 | 1.1 | 1.06 | -1.03 | -1.09 | 1.15 | -1.16 |
cation-transporting ATPase activity | 26 | 1.1 | 1.0 | 1.24 | -1.08 | 1.02 | 1.51 | -1.05 |
copper-exporting ATPase activity | 1 | -2.22 | 1.33 | 3.02 | 1.07 | -1.16 | -1.12 | 1.08 |
phospholipid-translocating ATPase activity | 6 | -2.65 | 1.11 | -1.12 | 1.22 | 1.24 | -1.33 | -1.09 |
adenosylhomocysteinase activity | 3 | -2.93 | -1.82 | -1.21 | -1.07 | 1.22 | 1.86 | -1.16 |
adenosylmethionine decarboxylase activity | 1 | 1.82 | 1.07 | 1.08 | 1.22 | 1.03 | 1.75 | -1.05 |
adenylate kinase activity | 6 | 1.61 | -1.18 | 1.01 | 1.04 | 1.05 | 1.04 | -1.33 |
adenylosuccinate synthase activity | 1 | 2.08 | 1.19 | 1.56 | -1.1 | -1.15 | 1.56 | -1.05 |
adenylylsulfate kinase activity | 1 | -2.63 | 1.06 | 1.41 | 1.07 | 1.11 | -1.64 | -1.02 |
L-alanine:2-oxoglutarate aminotransferase activity | 1 | -2.33 | 1.13 | 1.14 | 1.09 | 1.76 | 1.77 | -1.09 |
alcohol dehydrogenase (NAD) activity | 5 | 1.66 | -1.09 | -1.8 | -1.39 | -1.21 | 1.37 | 1.27 |
aldehyde dehydrogenase (NAD) activity | 3 | -1.65 | 1.15 | -1.65 | 1.05 | -1.41 | -1.9 | -1.31 |
aldehyde dehydrogenase [NAD(P)+] activity | 1 | 1.67 | -1.24 | -1.26 | 1.36 | 2.03 | -1.43 | 1.25 |
aldose 1-epimerase activity | 3 | -1.46 | 1.17 | -1.47 | -1.07 | 1.13 | -1.58 | -1.03 |
alkaline phosphatase activity | 13 | -5.32 | -1.81 | -4.2 | -1.19 | -1.19 | -4.42 | -4.05 |
allantoinase activity | 1 | 2.85 | -1.01 | 1.16 | 1.03 | -1.08 | 1.74 | -1.1 |
amidase activity | 1 | 1.54 | -1.32 | 2.9 | 1.39 | -1.83 | -6.19 | -2.79 |
amidophosphoribosyltransferase activity | 2 | 1.11 | 1.02 | -1.15 | -1.13 | -1.43 | 1.89 | -1.09 |
aminoacyl-tRNA hydrolase activity | 3 | 1.72 | -1.02 | 1.14 | 1.1 | 1.0 | 1.49 | -1.08 |
aminoacylase activity | 6 | -1.72 | -1.86 | -1.07 | -1.63 | 1.29 | -1.6 | -1.71 |
aminomethyltransferase activity | 4 | 1.27 | 1.14 | 1.17 | 1.01 | -1.01 | 1.6 | 1.08 |
nucleoside-diphosphatase activity | 3 | -2.29 | 1.44 | -2.09 | 1.33 | -1.38 | -3.32 | 1.1 |
arginase activity | 2 | 1.73 | -1.09 | 1.02 | -1.05 | -1.18 | 2.27 | 1.17 |
argininosuccinate synthase activity | 1 | -31.89 | 1.77 | -20.72 | 1.41 | 1.0 | -12.66 | -3.5 |
argininosuccinate lyase activity | 1 | -15.39 | 1.51 | -7.96 | 1.39 | 1.15 | -4.77 | -1.11 |
arginyltransferase activity | 1 | 1.03 | 1.39 | 1.46 | 1.24 | 1.37 | 1.69 | 1.36 |
aromatic-L-amino-acid decarboxylase activity | 4 | 2.04 | -1.66 | -1.74 | -1.59 | -1.59 | 1.51 | 1.84 |
aralkylamine N-acetyltransferase activity | 1 | -8.98 | 1.77 | -2.05 | -1.02 | -2.08 | -14.22 | 1.22 |
arylamine N-acetyltransferase activity | 1 | -8.98 | 1.77 | -2.05 | -1.02 | -2.08 | -14.22 | 1.22 |
aryldialkylphosphatase activity | 1 | 1.9 | -1.44 | -1.39 | -2.02 | 1.17 | 21.38 | -1.25 |
asparaginase activity | 4 | 1.31 | -1.05 | -1.24 | -1.15 | 1.04 | 1.97 | 1.03 |
L-aspartate:2-oxoglutarate aminotransferase activity | 2 | 1.83 | 1.18 | -1.32 | -1.0 | 1.19 | 1.57 | 1.14 |
aspartate carbamoyltransferase activity | 1 | -1.12 | 1.14 | 1.63 | 1.21 | 1.33 | 1.0 | 1.05 |
biliverdin reductase activity | 1 | -1.51 | 1.45 | 1.08 | 1.06 | -1.12 | -1.58 | -1.42 |
biotin carboxylase activity | 3 | 2.88 | 1.25 | -1.21 | -1.16 | -1.0 | 2.26 | 1.91 |
bis(5'-nucleosyl)-tetraphosphatase (asymmetrical) activity | 1 | -1.85 | 1.12 | 1.37 | 1.12 | 1.23 | -1.02 | 1.02 |
branched-chain-amino-acid transaminase activity | 1 | 5.21 | 1.63 | 1.44 | -1.45 | -2.46 | 1.42 | 2.6 |
carbamoyl-phosphate synthase (ammonia) activity | 1 | -1.12 | 1.14 | 1.63 | 1.21 | 1.33 | 1.0 | 1.05 |
carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity | 1 | -1.12 | 1.14 | 1.63 | 1.21 | 1.33 | 1.0 | 1.05 |
carbonyl reductase (NADPH) activity | 3 | 1.57 | 1.0 | -1.52 | -1.25 | -1.09 | 1.43 | 1.09 |
carnitine O-palmitoyltransferase activity | 1 | 1.55 | 1.41 | -1.09 | 1.13 | 1.34 | -1.06 | 1.05 |
catalase activity | 3 | 1.88 | -1.66 | -2.02 | -1.59 | -1.55 | 2.15 | -1.21 |
catechol oxidase activity | 1 | 1.73 | 1.33 | 1.02 | 1.13 | -1.06 | -1.05 | 1.06 |
chitin deacetylase activity | 2 | 2.14 | -1.13 | 1.05 | -1.06 | -1.29 | -1.18 | -1.25 |
chitin synthase activity | 2 | -4.74 | 1.25 | 1.37 | -1.3 | 1.38 | 1.09 | 1.15 |
choline kinase activity | 2 | 1.11 | 1.13 | 1.36 | 1.19 | 1.43 | 2.57 | 1.13 |
cholinesterase activity | 2 | -1.12 | 1.28 | -2.63 | -1.13 | -1.28 | -3.75 | 2.43 |
choline-phosphate cytidylyltransferase activity | 2 | 1.06 | -1.23 | 1.07 | 1.02 | 1.15 | -1.4 | 1.55 |
coproporphyrinogen oxidase activity | 1 | -1.38 | 1.31 | 1.39 | 1.26 | 1.22 | -1.88 | -1.39 |
cyclic-nucleotide phosphodiesterase activity | 8 | 1.68 | 1.07 | 1.28 | 1.01 | 1.26 | 2.25 | 1.48 |
3',5'-cyclic-nucleotide phosphodiesterase activity | 8 | 1.68 | 1.07 | 1.28 | 1.01 | 1.26 | 2.25 | 1.48 |
3',5'-cyclic-AMP phosphodiesterase activity | 4 | 1.06 | 1.26 | 1.31 | 1.05 | 1.3 | 1.79 | 1.4 |
cystathionine beta-synthase activity | 1 | 1.25 | 1.1 | 1.48 | -1.98 | -7.11 | -1.17 | 2.59 |
cytidine deaminase activity | 3 | -2.8 | 1.04 | -1.39 | 1.2 | 1.32 | -1.87 | -1.06 |
cytosine deaminase activity | 1 | 1.58 | 1.21 | -1.04 | 1.33 | -1.0 | -1.93 | 1.34 |
dCMP deaminase activity | 1 | 2.54 | -1.17 | -1.05 | 1.35 | 1.96 | 1.77 | -1.1 |
glycogen debranching enzyme activity | 1 | 1.91 | -1.57 | -1.98 | 1.36 | -1.16 | 2.47 | 1.07 |
4-alpha-glucanotransferase activity | 1 | 1.91 | -1.57 | -1.98 | 1.36 | -1.16 | 2.47 | 1.07 |
amylo-alpha-1,6-glucosidase activity | 1 | 1.91 | -1.57 | -1.98 | 1.36 | -1.16 | 2.47 | 1.07 |
deoxyribose-phosphate aldolase activity | 1 | -1.52 | 1.52 | -1.38 | 1.37 | -1.06 | -2.8 | 1.21 |
dephospho-CoA kinase activity | 2 | 1.04 | 1.25 | -1.2 | 1.45 | 1.19 | -1.52 | -1.32 |
diacylglycerol cholinephosphotransferase activity | 1 | -3.65 | 1.65 | 3.17 | 1.08 | 1.15 | -2.09 | 2.51 |
diacylglycerol kinase activity | 8 | 1.65 | 1.05 | -1.03 | -1.02 | -1.04 | 1.17 | 1.24 |
diacylglycerol O-acyltransferase activity | 1 | -1.05 | 1.33 | 3.49 | 1.16 | 1.98 | 2.09 | 1.25 |
dihydrofolate reductase activity | 1 | 2.25 | -1.1 | -1.03 | 1.28 | 1.09 | 2.14 | -1.24 |
dihydrolipoamide branched chain acyltransferase activity | 1 | 1.74 | 1.44 | 1.67 | 1.01 | 1.35 | 1.38 | 1.19 |
dihydrolipoyl dehydrogenase activity | 1 | -1.4 | -1.14 | 2.27 | -1.25 | -1.48 | 1.94 | -1.5 |
dihydrolipoyllysine-residue succinyltransferase activity | 1 | 1.27 | -1.02 | 1.79 | -1.24 | 1.05 | 3.95 | -1.37 |
dihydroorotase activity | 1 | -1.12 | 1.14 | 1.63 | 1.21 | 1.33 | 1.0 | 1.05 |
6,7-dihydropteridine reductase activity | 1 | 2.26 | 1.17 | 1.35 | 1.12 | 1.23 | 1.64 | 1.14 |
dihydrouracil dehydrogenase (NAD+) activity | 1 | -2.4 | 1.52 | -1.09 | 1.53 | -1.18 | -2.54 | -1.54 |
dimethylallyltranstransferase activity | 2 | 2.38 | 1.13 | 2.21 | -1.02 | 1.58 | 1.4 | 1.7 |
diphosphomevalonate decarboxylase activity | 1 | 2.36 | -1.19 | -1.1 | 1.02 | -1.17 | 1.09 | 1.24 |
diphthine synthase activity | 1 | 1.75 | 1.22 | 1.1 | 1.3 | 1.08 | -1.18 | -1.03 |
dodecenoyl-CoA delta-isomerase activity | 5 | 1.65 | 1.02 | -1.16 | 1.25 | 1.08 | 1.17 | -1.36 |
dopachrome isomerase activity | 2 | 2.9 | -1.22 | -1.25 | -1.08 | -1.28 | 3.34 | -1.14 |
dolichol kinase activity | 1 | -2.66 | 1.27 | -1.76 | 1.39 | 1.67 | -4.72 | -1.84 |
dolichyl-phosphate-mannose-protein mannosyltransferase activity | 2 | 1.57 | 1.01 | 1.07 | -1.18 | -1.11 | 1.61 | 1.23 |
dUTP diphosphatase activity | 1 | -1.36 | -1.27 | 1.07 | 1.7 | 1.82 | -3.47 | -2.13 |
ecdysteroid UDP-glucosyltransferase activity | 2 | -2.06 | 1.41 | -1.15 | 1.08 | 1.07 | -2.31 | -1.09 |
electron-transferring-flavoprotein dehydrogenase activity | 1 | 2.09 | 1.59 | -1.41 | 1.19 | 1.36 | 1.02 | -1.19 |
endopeptidase activity | 433 | -1.75 | -1.28 | -1.35 | -1.08 | -1.23 | -1.79 | -1.45 |
aminopeptidase activity | 36 | -2.28 | -1.12 | -1.52 | 1.05 | 1.14 | -1.43 | -1.98 |
metalloexopeptidase activity | 41 | -2.37 | -1.56 | -1.46 | 1.02 | -1.31 | -2.4 | -1.85 |
carboxypeptidase activity | 35 | -2.91 | -1.85 | -1.55 | -1.01 | -1.63 | -3.14 | -1.86 |
metallocarboxypeptidase activity | 24 | -4.15 | -2.21 | -1.86 | -1.01 | -1.57 | -4.07 | -2.61 |
serine-type carboxypeptidase activity | 11 | -1.26 | -1.29 | -1.05 | -1.03 | -1.8 | -1.77 | 1.1 |
aspartic-type endopeptidase activity | 19 | -1.6 | -1.03 | 1.15 | -1.16 | -1.46 | -1.86 | -1.32 |
calcium-dependent cysteine-type endopeptidase activity | 4 | 2.12 | 1.16 | 1.44 | 1.14 | 1.21 | 1.24 | 1.16 |
lysosome | 28 | -2.58 | -1.1 | -2.35 | 1.15 | -1.08 | -2.06 | -3.03 |
pyroglutamyl-peptidase activity | 2 | 2.37 | -1.16 | 1.04 | -1.04 | 1.14 | 1.57 | 1.04 |
ubiquitin thiolesterase activity | 27 | 1.19 | 1.22 | 1.57 | 1.17 | 1.42 | 1.39 | 1.24 |
metallopeptidase activity | 153 | -1.78 | -1.24 | -1.3 | 1.02 | -1.0 | -1.44 | -1.51 |
peptidyl-dipeptidase activity | 6 | -1.43 | -1.17 | -1.51 | -1.07 | 1.03 | 1.0 | -1.19 |
vacuole | 54 | -2.1 | -1.04 | -1.32 | -1.01 | -1.13 | -1.28 | -1.9 |
serine-type peptidase activity | 288 | -2.24 | -1.4 | -1.61 | -1.12 | -1.45 | -2.28 | -1.59 |
tripeptidyl-peptidase activity | 2 | -2.48 | 1.24 | -1.3 | 1.26 | 1.28 | -1.53 | -1.15 |
peptidase activity | 576 | -1.77 | -1.28 | -1.36 | -1.05 | -1.15 | -1.74 | -1.45 |
epoxide hydrolase activity | 3 | -2.11 | 1.3 | -1.14 | -1.06 | -1.44 | -4.35 | 1.38 |
ethanolamine kinase activity | 2 | 1.11 | 1.13 | 1.36 | 1.19 | 1.43 | 2.57 | 1.13 |
ethanolamine-phosphate cytidylyltransferase activity | 1 | 1.81 | -1.85 | 1.07 | -1.42 | 1.03 | 1.7 | 2.82 |
ethanolaminephosphotransferase activity | 1 | -1.35 | 1.28 | 1.66 | 1.08 | 1.2 | 1.32 | 1.18 |
farnesyltranstransferase activity | 2 | 1.07 | 1.18 | 1.54 | 1.21 | 1.32 | 1.31 | -1.04 |
fatty acid synthase activity | 8 | 1.58 | -1.38 | -1.32 | -1.5 | -1.29 | 1.18 | 1.72 |
[acyl-carrier-protein] S-acetyltransferase activity | 2 | 3.49 | -1.07 | -1.08 | -1.15 | 1.4 | 1.97 | 2.1 |
[acyl-carrier-protein] S-malonyltransferase activity | 3 | 2.14 | -1.05 | -1.1 | -1.07 | 1.17 | 1.47 | 1.42 |
3-oxoacyl-[acyl-carrier-protein] synthase activity | 3 | 2.25 | -1.02 | -1.08 | -1.11 | 1.15 | 1.9 | 1.44 |
3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity | 2 | 3.49 | -1.07 | -1.08 | -1.15 | 1.4 | 1.97 | 2.1 |
3-hydroxypalmitoyl-[acyl-carrier-protein] dehydratase activity | 2 | 3.49 | -1.07 | -1.08 | -1.15 | 1.4 | 1.97 | 2.1 |
enoyl-[acyl-carrier-protein] reductase (NADPH, B-specific) activity | 2 | 3.49 | -1.07 | -1.08 | -1.15 | 1.4 | 1.97 | 2.1 |
oleoyl-[acyl-carrier-protein] hydrolase activity | 2 | 3.49 | -1.07 | -1.08 | -1.15 | 1.4 | 1.97 | 2.1 |
fatty-acyl-CoA synthase activity | 1 | 2.47 | -1.2 | -1.84 | 1.79 | 2.31 | -2.71 | -1.43 |
ferroxidase activity | 3 | -1.88 | -2.6 | -2.43 | -2.04 | 1.07 | -1.41 | 2.03 |
iron ion transmembrane transporter activity | 7 | 1.31 | -1.87 | -2.05 | -1.74 | -1.19 | 1.52 | 1.79 |
ferredoxin-NADP+ reductase activity | 1 | -1.19 | 1.24 | 1.2 | 1.43 | 1.53 | -1.12 | -1.13 |
tetrahydrofolylpolyglutamate synthase activity | 2 | -1.63 | 1.22 | -1.26 | 1.27 | -1.21 | -1.7 | -1.32 |
S-(hydroxymethyl)glutathione dehydrogenase activity | 1 | 1.29 | 1.1 | 1.03 | 1.22 | 1.29 | 1.66 | -1.14 |
formate-tetrahydrofolate ligase activity | 1 | -2.72 | 1.36 | -1.4 | 1.55 | -1.7 | -1.17 | -2.58 |
fructose-2,6-bisphosphate 2-phosphatase activity | 1 | 1.09 | -1.34 | 2.59 | -1.04 | 1.14 | 3.38 | -1.06 |
fructose-bisphosphate aldolase activity | 1 | 1.83 | 1.08 | -1.27 | -1.04 | 1.23 | 2.05 | 1.42 |
fumarylacetoacetase activity | 1 | 2.81 | -1.06 | -1.21 | -1.09 | 1.58 | 2.01 | -1.24 |
geranyltranstransferase activity | 2 | 2.38 | 1.13 | 2.21 | -1.02 | 1.58 | 1.4 | 1.7 |
glucosamine-6-phosphate deaminase activity | 1 | -1.22 | 1.14 | 1.64 | 1.24 | 2.02 | -2.96 | -2.72 |
glucosamine 6-phosphate N-acetyltransferase activity | 1 | 1.02 | 1.09 | -1.02 | 1.16 | 1.08 | -1.06 | 2.5 |
glucose dehydrogenase activity | 4 | 2.07 | -1.33 | -1.32 | -1.38 | -1.39 | 2.15 | -1.49 |
glucose-6-phosphate dehydrogenase activity | 2 | 1.97 | -1.14 | -2.0 | -1.18 | -1.53 | 1.18 | 1.65 |
glucose-6-phosphate isomerase activity | 1 | 4.0 | 1.26 | -2.38 | -1.3 | -1.5 | 3.87 | 2.36 |
glucosylceramidase activity | 3 | -3.7 | -1.06 | -2.39 | 1.57 | -1.6 | -3.65 | -2.05 |
glutamate 5-kinase activity | 1 | -29.94 | 1.93 | -2.31 | -1.05 | -1.13 | -7.63 | 1.24 |
glutamate-5-semialdehyde dehydrogenase activity | 1 | -29.94 | 1.93 | -2.31 | -1.05 | -1.13 | -7.63 | 1.24 |
glutamate dehydrogenase (NAD+) activity | 1 | -1.32 | -1.9 | 1.3 | -2.14 | 3.35 | 4.87 | -4.48 |
glutamate dehydrogenase [NAD(P)+] activity | 2 | -1.13 | -1.34 | 1.15 | -1.41 | 1.89 | 2.28 | -2.14 |
glutamate synthase (NADPH) activity | 1 | 2.14 | 1.19 | 1.24 | 1.03 | -1.73 | 3.68 | 2.51 |
glutamate-ammonia ligase activity | 2 | 1.91 | -1.99 | 2.01 | -1.44 | 1.52 | -1.73 | -1.25 |
glutamate-cysteine ligase activity | 2 | -1.84 | 1.49 | -1.21 | 1.04 | -1.06 | 1.03 | 1.54 |
glutamine-fructose-6-phosphate transaminase (isomerizing) activity | 2 | -1.0 | -1.44 | 1.48 | -1.44 | 1.38 | 1.11 | 2.78 |
glutaryl-CoA dehydrogenase activity | 1 | -1.51 | -1.6 | -1.42 | 1.8 | -1.74 | 2.0 | -2.55 |
glutathione-disulfide reductase activity | 1 | -1.86 | 1.42 | -1.95 | 1.12 | 1.15 | -1.81 | 1.13 |
glutathione synthase activity | 1 | -4.56 | 1.3 | -1.17 | 1.44 | -1.72 | -2.63 | -1.17 |
glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity | 3 | 1.41 | -1.11 | -1.14 | -1.08 | -1.06 | 1.76 | 1.01 |
glycerol-3-phosphate O-acyltransferase activity | 2 | 3.16 | -1.05 | -1.54 | 1.04 | 2.3 | -1.34 | 1.05 |
glycerol-3-phosphate dehydrogenase [NAD+] activity | 2 | 1.2 | 1.12 | -1.49 | 1.16 | 1.79 | -1.21 | -1.08 |
glycine hydroxymethyltransferase activity | 1 | 4.17 | -1.15 | 1.23 | 1.12 | 1.08 | 1.16 | -1.19 |
glycogen (starch) synthase activity | 1 | 3.34 | -1.14 | 1.48 | -1.05 | 1.39 | 2.94 | 1.3 |
glycine decarboxylation via glycine cleavage system | 1 | 1.73 | -1.01 | 1.7 | -1.04 | 1.38 | 3.31 | -1.03 |
glycine dehydrogenase (decarboxylating) activity | 1 | -1.37 | -1.08 | -1.16 | -1.21 | -1.14 | 1.68 | -1.06 |
glycolipid mannosyltransferase activity | 1 | -1.85 | 1.22 | -1.04 | 1.31 | 1.1 | -2.17 | 1.06 |
glycylpeptide N-tetradecanoyltransferase activity | 1 | -1.49 | 1.29 | 1.71 | 1.24 | 1.7 | 1.05 | 1.0 |
guanosine-diphosphatase activity | 1 | -1.51 | 1.28 | -1.3 | 1.09 | -1.1 | -3.57 | 1.37 |
guanylate kinase activity | 5 | 3.22 | 1.04 | 1.21 | -1.15 | 1.05 | 2.62 | 1.29 |
heme oxygenase (decyclizing) activity | 1 | 2.0 | 1.05 | 2.09 | 1.06 | 1.46 | 2.34 | 1.12 |
heparan sulfate 2-O-sulfotransferase activity | 2 | 2.25 | 1.13 | 1.26 | 1.01 | 1.22 | 1.54 | 1.62 |
hexokinase activity | 4 | -1.31 | 1.0 | -1.96 | 1.11 | 1.37 | 1.21 | -1.77 |
holocytochrome-c synthase activity | 1 | 1.66 | 1.03 | 1.71 | 1.06 | 1.0 | 2.28 | -1.41 |
hyalurononglucosaminidase activity | 1 | 1.16 | 1.5 | 1.47 | 1.26 | 1.67 | 1.16 | 1.31 |
hydroxyacylglutathione hydrolase activity | 1 | -2.43 | 1.25 | -1.81 | 1.44 | 1.13 | -2.07 | -1.36 |
hydroxymethylglutaryl-CoA lyase activity | 1 | -1.23 | 1.82 | 1.48 | 1.33 | 1.52 | 1.63 | 1.08 |
hydroxymethylglutaryl-CoA synthase activity | 1 | 1.84 | -1.29 | 1.3 | -1.14 | 1.76 | 1.59 | 1.19 |
iduronate-2-sulfatase activity | 1 | 1.62 | 1.05 | 1.28 | 1.01 | 1.11 | 1.28 | 1.12 |
phosphatidylinositol phosphate kinase activity | 6 | -1.3 | 1.22 | 1.48 | 1.12 | 1.58 | 1.08 | 1.01 |
phosphatidylinositol kinase activity | 5 | -1.09 | 1.17 | 1.62 | 1.11 | 1.75 | 1.32 | 1.12 |
phosphatidylinositol bisphosphate kinase activity | 3 | -1.46 | 1.15 | 1.53 | 1.18 | 1.77 | -1.09 | -1.14 |
1-phosphatidylinositol 4-kinase activity | 2 | 1.44 | 1.21 | 1.76 | 1.02 | 1.71 | 2.28 | 1.63 |
phosphatidylinositol phospholipase C activity | 2 | 2.58 | 1.12 | 1.89 | -1.08 | 1.02 | 1.84 | 1.76 |
phosphatidylinositol trisphosphate phosphatase activity | 1 | 2.96 | 1.13 | 1.75 | -1.2 | 1.98 | 1.94 | 1.75 |
inositol phosphate phosphatase activity | 13 | 1.85 | -1.04 | -1.08 | -1.1 | 1.15 | 1.89 | 1.3 |
phosphatidylinositol-3-phosphatase activity | 1 | -1.51 | 1.05 | 1.08 | 1.24 | -1.11 | -1.13 | -1.35 |
inositol-1,4-bisphosphate 1-phosphatase activity | 1 | 3.45 | -1.15 | 1.32 | 1.0 | -1.07 | 1.6 | -1.16 |
inositol trisphosphate phosphatase activity | 6 | 1.66 | 1.07 | 1.37 | -1.03 | 1.33 | 2.5 | 1.26 |
inositol-polyphosphate 5-phosphatase activity | 3 | 1.23 | 1.22 | 1.55 | 1.08 | 1.34 | 1.47 | 1.38 |
isocitrate dehydrogenase activity | 7 | 1.09 | 1.14 | 1.28 | -1.23 | 1.01 | 1.93 | 1.09 |
isocitrate dehydrogenase (NAD+) activity | 6 | 1.03 | 1.08 | 1.46 | -1.19 | 1.02 | 2.18 | 1.06 |
isocitrate dehydrogenase (NADP+) activity | 1 | 1.5 | 1.55 | -1.65 | -1.56 | -1.01 | -1.09 | 1.26 |
isopentenyl-diphosphate delta-isomerase activity | 1 | 3.32 | -1.02 | 1.27 | 1.26 | 1.27 | 1.92 | 1.53 |
lactate dehydrogenase activity | 2 | 1.05 | 1.2 | 1.7 | -1.34 | -1.08 | -2.44 | 1.33 |
L-lactate dehydrogenase activity | 2 | 1.05 | 1.2 | 1.7 | -1.34 | -1.08 | -2.44 | 1.33 |
lactoylglutathione lyase activity | 1 | -1.59 | 1.09 | -1.01 | 1.22 | -1.05 | -1.39 | -1.43 |
leukotriene-A4 hydrolase activity | 1 | -1.74 | 1.11 | -2.01 | 1.51 | 1.27 | -1.87 | -1.55 |
lipoprotein lipase activity | 5 | -2.69 | -1.1 | -1.42 | 1.06 | 1.23 | -1.76 | -1.32 |
long-chain fatty acid-CoA ligase activity | 7 | 1.81 | -1.3 | -1.35 | 1.09 | 1.2 | -1.91 | -1.26 |
malic enzyme activity | 4 | -1.07 | 1.26 | 1.14 | -1.52 | -1.06 | 1.05 | 1.65 |
malate dehydrogenase (oxaloacetate-decarboxylating) (NADP+) activity | 4 | -1.07 | 1.26 | 1.14 | -1.52 | -1.06 | 1.05 | 1.65 |
mannose-1-phosphate guanylyltransferase activity | 2 | -2.09 | 1.14 | 1.2 | 1.25 | 1.24 | -1.89 | 1.17 |
mannose-6-phosphate isomerase activity | 2 | 3.41 | 1.03 | 1.33 | -1.05 | -1.02 | 3.9 | 1.9 |
methenyltetrahydrofolate cyclohydrolase activity | 2 | 1.63 | -1.3 | -1.28 | -1.04 | -1.47 | 2.82 | -1.53 |
methionine adenosyltransferase activity | 1 | 1.6 | 1.05 | 1.23 | -1.23 | 1.41 | 1.78 | 1.98 |
methionyl-tRNA formyltransferase activity | 1 | 1.38 | 1.09 | 1.78 | 1.2 | 1.53 | 2.7 | -1.25 |
mRNA guanylyltransferase activity | 1 | 1.69 | 1.28 | 1.3 | 1.3 | 1.17 | 1.5 | 1.34 |
methylcrotonoyl-CoA carboxylase activity | 2 | 1.38 | 1.49 | 1.32 | 1.28 | 1.37 | 1.61 | 1.17 |
methylenetetrahydrofolate dehydrogenase [NAD(P)+] activity | 1 | 2.55 | -3.49 | -3.06 | -4.0 | -1.9 | 6.63 | -1.86 |
methylenetetrahydrofolate dehydrogenase (NAD+) activity | 1 | 7.21 | -2.31 | -1.17 | -1.68 | -1.27 | 9.3 | 1.1 |
methylenetetrahydrofolate dehydrogenase (NADP+) activity | 2 | 1.63 | -1.3 | -1.28 | -1.04 | -1.47 | 2.82 | -1.53 |
methylenetetrahydrofolate reductase (NADPH) activity | 1 | 1.73 | -1.17 | -1.14 | -1.13 | -1.11 | 2.12 | -1.29 |
methylmalonate-semialdehyde dehydrogenase (acylating) activity | 1 | -1.74 | 1.44 | -1.08 | -1.1 | -1.07 | 1.5 | 1.28 |
monooxygenase activity | 35 | 1.52 | -1.2 | -1.23 | -1.13 | -1.16 | -1.04 | 1.06 |
N,N-dimethylaniline monooxygenase activity | 2 | 1.33 | 1.51 | -1.79 | -1.37 | -1.35 | 1.43 | 1.59 |
peptidylglycine monooxygenase activity | 1 | 2.74 | 1.3 | 1.75 | 1.08 | 1.98 | 1.97 | 2.28 |
phenylalanine 4-monooxygenase activity | 2 | 1.24 | -1.3 | -1.46 | -1.42 | -1.18 | 2.11 | -1.36 |
tryptophan 5-monooxygenase activity | 2 | 1.24 | -1.3 | -1.46 | -1.42 | -1.18 | 2.11 | -1.36 |
tyrosine 3-monooxygenase activity | 1 | -1.05 | -1.1 | 1.05 | 1.12 | -1.1 | -1.1 | 1.78 |
inositol-3-phosphate synthase activity | 1 | 1.86 | -1.46 | -1.12 | -1.51 | 1.13 | 1.83 | 1.71 |
nicotinate-nucleotide diphosphorylase (carboxylating) activity | 1 | 8.31 | 1.05 | -1.79 | -1.54 | -1.19 | 1.17 | 2.54 |
nicotinate phosphoribosyltransferase activity | 1 | 8.31 | 1.05 | -1.79 | -1.54 | -1.19 | 1.17 | 2.54 |
ribonuclease III activity | 4 | 1.01 | 1.12 | 1.7 | -1.0 | 1.33 | 1.5 | 1.2 |
deoxyribonuclease II activity | 1 | 3.57 | -3.74 | -3.12 | -4.14 | -2.27 | -1.33 | 4.32 |
5'-3' exoribonuclease activity | 2 | -1.11 | 1.53 | 1.16 | 1.33 | 1.34 | -1.11 | 1.19 |
poly(A)-specific ribonuclease activity | 2 | 1.33 | 1.15 | 1.69 | 1.2 | 1.62 | 2.01 | 1.48 |
octanol dehydrogenase activity | 1 | 1.29 | 1.1 | 1.03 | 1.22 | 1.29 | 1.66 | -1.14 |
hydrolase activity, hydrolyzing O-glycosyl compounds | 93 | -1.83 | -1.29 | -2.4 | -1.22 | -1.47 | -1.78 | -1.26 |
alpha,alpha-trehalase activity | 3 | -2.73 | 1.23 | -2.68 | 1.17 | -1.22 | -2.41 | 1.01 |
alpha-amylase activity | 2 | -34.84 | -2.22 | -3.89 | 2.13 | -10.58 | -52.06 | -2.46 |
alpha-galactosidase activity | 1 | -4.17 | 1.11 | -1.19 | -1.11 | -1.3 | -2.49 | 3.87 |
alpha-glucosidase activity | 13 | -7.82 | -1.11 | -3.92 | 1.01 | -2.19 | -4.92 | -2.34 |
alpha-mannosidase activity | 9 | -14.64 | -1.14 | -7.39 | 1.54 | -1.15 | -14.33 | -25.61 |
alpha-L-fucosidase activity | 1 | -1.1 | -1.19 | -1.53 | -1.9 | -1.86 | -1.28 | 7.99 |
alpha-N-acetylglucosaminidase activity | 1 | -1.03 | -1.29 | -2.28 | -2.21 | -1.93 | 20.24 | 3.19 |
beta-N-acetylhexosaminidase activity | 4 | 2.6 | -1.04 | -1.38 | 1.02 | 1.14 | -1.03 | 1.23 |
beta-galactosidase activity | 2 | -4.22 | 1.94 | -2.65 | -1.31 | -2.65 | -1.75 | -2.68 |
beta-glucuronidase activity | 2 | -2.98 | 1.22 | 1.8 | 1.28 | 1.95 | -1.65 | 1.15 |
beta-mannosidase activity | 1 | -5.95 | 1.18 | 1.25 | 1.37 | 1.4 | -3.3 | -1.02 |
chitinase activity | 17 | -1.5 | -2.2 | -3.34 | -2.35 | -1.62 | 1.11 | 2.06 |
mannosyl-oligosaccharide 1,2-alpha-mannosidase activity | 5 | 1.56 | 1.24 | -1.27 | -1.11 | -1.07 | 2.0 | 1.29 |
mannosyl-oligosaccharide 1,3-1,6-alpha-mannosidase activity | 2 | 2.21 | -1.18 | -1.12 | 1.09 | -1.0 | 4.22 | 1.53 |
mannosyl-oligosaccharide glucosidase activity | 1 | 1.11 | 1.54 | -1.06 | 1.25 | 1.09 | -1.47 | 1.06 |
oligo-1,6-glucosidase activity | 1 | -7.77 | -4.97 | -3.61 | 4.46 | -5.62 | -8.7 | -6.61 |
dolichyl-diphosphooligosaccharide-protein glycotransferase activity | 2 | -2.3 | 1.16 | -1.02 | 1.14 | 1.1 | -1.42 | 1.33 |
dolichyl-phosphate beta-glucosyltransferase activity | 1 | -1.18 | 1.16 | 1.9 | 1.06 | 1.5 | -1.14 | 1.68 |
dolichyl-phosphate beta-D-mannosyltransferase activity | 1 | 1.01 | 1.25 | 1.35 | 1.09 | 1.77 | -1.32 | 1.33 |
ornithine decarboxylase activity | 2 | -1.3 | -1.56 | -1.58 | -1.19 | -1.51 | 1.68 | -1.8 |
ornithine-oxo-acid transaminase activity | 2 | -3.39 | 1.33 | -4.62 | 1.16 | 1.17 | -3.49 | 1.2 |
orotate phosphoribosyltransferase activity | 1 | 1.61 | 1.06 | 1.09 | 1.15 | 1.38 | -1.09 | 1.01 |
orotidine-5'-phosphate decarboxylase activity | 1 | 1.61 | 1.06 | 1.09 | 1.15 | 1.38 | -1.09 | 1.01 |
oxoglutarate dehydrogenase (succinyl-transferring) activity | 2 | -2.58 | 1.25 | 1.08 | -1.04 | 1.34 | -1.08 | -1.45 |
pantothenate kinase activity | 1 | 2.17 | 1.37 | -1.41 | 1.23 | 1.4 | -1.72 | 1.12 |
pantetheine-phosphate adenylyltransferase activity | 1 | -1.07 | 1.17 | -1.47 | 1.46 | 1.3 | -2.5 | -1.32 |
peptide alpha-N-acetyltransferase activity | 2 | -1.32 | 1.41 | 1.74 | 1.19 | 1.16 | -1.05 | -1.05 |
cyclosporin A binding | 1 | -1.56 | 1.12 | -1.6 | -1.09 | -1.49 | -1.56 | -1.26 |
glutathione peroxidase activity | 8 | -1.36 | 1.09 | -1.0 | -1.35 | -1.25 | -2.14 | 1.1 |
phosphatidate cytidylyltransferase activity | 1 | 3.07 | 1.1 | 2.07 | -1.42 | 3.13 | -1.11 | 1.4 |
phosphatidylserine decarboxylase activity | 1 | 2.68 | -1.15 | 1.36 | 1.05 | 1.26 | 2.6 | 1.26 |
phosphoacetylglucosamine mutase activity | 1 | -2.86 | 1.51 | 1.12 | 1.09 | 1.09 | -5.18 | 1.1 |
phosphoenolpyruvate carboxykinase activity | 2 | -2.6 | -1.77 | 1.37 | -1.78 | 2.07 | 1.05 | -1.67 |
phosphoenolpyruvate carboxykinase (GTP) activity | 2 | -2.6 | -1.77 | 1.37 | -1.78 | 2.07 | 1.05 | -1.67 |
phosphoglucomutase activity | 1 | 3.54 | -1.2 | -2.31 | -1.28 | -1.28 | 4.52 | 1.34 |
phosphogluconate dehydrogenase (decarboxylating) activity | 4 | 1.7 | 1.24 | -1.62 | -1.03 | -1.05 | 1.36 | 1.59 |
phosphoglycerate dehydrogenase activity | 2 | 2.82 | -1.08 | -1.11 | 1.42 | -1.05 | 1.77 | -1.02 |
phosphoglycerate kinase activity | 2 | 1.52 | -1.04 | -1.22 | 1.01 | -1.05 | 1.8 | -1.0 |
phosphoglycerate mutase activity | 4 | 1.53 | -1.02 | -1.23 | -1.07 | -1.15 | 1.51 | 1.11 |
phospholipase activity | 42 | -2.02 | -1.32 | -1.4 | -1.24 | -1.44 | -1.94 | -1.19 |
lysophospholipase activity | 5 | -1.5 | -1.08 | -1.31 | -1.5 | -1.48 | 1.02 | 1.77 |
phospholipase A2 activity | 10 | 1.72 | -1.05 | -1.16 | -1.1 | -1.05 | -1.02 | 1.07 |
calcium-independent phospholipase A2 activity | 2 | 1.71 | 1.33 | 1.36 | 1.12 | 1.41 | 1.4 | 1.33 |
phosphomevalonate kinase activity | 1 | 2.16 | -1.1 | 1.03 | -1.13 | 1.06 | 2.2 | 1.18 |
phosphopantothenate--cysteine ligase activity | 1 | -1.95 | 1.39 | 1.68 | 1.01 | 1.49 | -1.24 | 1.08 |
phosphopantothenoylcysteine decarboxylase activity | 1 | 3.72 | -1.03 | 1.39 | 1.15 | 1.52 | 2.47 | 1.16 |
phosphopyruvate hydratase activity | 1 | 1.97 | 1.06 | -1.39 | -1.17 | -1.32 | 2.59 | 1.17 |
phosphoribosylaminoimidazole carboxylase activity | 2 | -1.17 | -1.46 | -1.46 | -1.15 | -1.17 | 1.65 | -1.07 |
phosphoribosylaminoimidazolesuccinocarboxamide synthase activity | 2 | -1.17 | -1.46 | -1.46 | -1.15 | -1.17 | 1.65 | -1.07 |
phosphoribosylformylglycinamidine synthase activity | 1 | -1.91 | 1.54 | -1.81 | 1.0 | -1.5 | -1.22 | 1.08 |
phosphoribosylaminoimidazolecarboxamide formyltransferase activity | 1 | -1.39 | 1.0 | -1.49 | -1.01 | -1.06 | 1.63 | -1.09 |
phosphorylase activity | 1 | 2.98 | -1.08 | 1.5 | -1.31 | 1.12 | 4.86 | 1.33 |
phosphoserine phosphatase activity | 1 | 2.48 | 1.99 | -2.53 | -1.16 | 1.91 | 2.86 | 1.87 |
O-phospho-L-serine:2-oxoglutarate aminotransferase activity | 1 | 2.63 | -1.02 | -1.9 | 1.11 | -1.04 | 2.51 | 1.93 |
poly(ADP-ribose) glycohydrolase activity | 1 | 1.16 | 1.03 | 1.19 | 1.34 | 1.67 | -1.1 | 1.01 |
polynucleotide 5'-phosphatase activity | 1 | 1.69 | 1.28 | 1.3 | 1.3 | 1.17 | 1.5 | 1.34 |
polypeptide N-acetylgalactosaminyltransferase activity | 14 | -1.29 | -1.23 | -1.25 | -1.28 | -1.26 | -1.61 | 1.75 |
porphobilinogen synthase activity | 1 | -2.33 | 1.65 | -1.72 | 1.07 | -2.09 | -1.28 | -1.14 |
iron ion transport | 7 | 1.59 | -1.3 | -1.22 | -1.23 | -1.14 | 1.5 | 1.12 |
proline dehydrogenase activity | 1 | 2.07 | -7.1 | -4.47 | -7.74 | -3.15 | 31.25 | -1.33 |
protein farnesyltransferase activity | 1 | -1.83 | -1.28 | -1.22 | 1.05 | -1.01 | -1.04 | 2.75 |
protein geranylgeranyltransferase activity | 6 | -1.57 | 1.19 | 1.22 | 1.14 | 1.21 | -1.62 | 1.21 |
CAAX-protein geranylgeranyltransferase activity | 2 | -2.28 | 1.15 | 1.11 | 1.06 | 1.05 | -2.22 | 1.78 |
protein C-terminal S-isoprenylcysteine carboxyl O-methyltransferase activity | 1 | -2.13 | 1.18 | 1.09 | 1.41 | 1.8 | -1.71 | -1.76 |
protein histidine kinase activity | 3 | 1.12 | -1.13 | 1.03 | -1.08 | 1.69 | 1.52 | -1.14 |
transmembrane receptor protein serine/threonine kinase activity | 5 | -1.03 | 1.52 | 1.48 | 1.18 | 1.61 | 1.07 | 1.49 |
DNA-dependent protein kinase activity | 1 | 1.33 | 1.54 | 1.93 | 1.1 | 1.72 | 1.13 | 1.74 |
calmodulin-dependent protein kinase activity | 8 | 2.03 | 1.07 | 1.21 | 1.02 | 1.3 | 2.02 | 1.5 |
elongation factor-2 kinase activity | 2 | 1.62 | 1.17 | 1.62 | -1.04 | 1.48 | 1.47 | 1.77 |
myosin light chain kinase activity | 4 | 1.66 | -1.14 | 1.36 | -1.04 | 1.61 | 1.38 | 1.02 |
phosphorylase kinase activity | 1 | 1.92 | 1.23 | 1.07 | 1.1 | 1.35 | 3.19 | 1.58 |
cyclic nucleotide-dependent protein kinase activity | 6 | -1.04 | -1.05 | 1.23 | -1.15 | 1.2 | 2.46 | 1.34 |
cAMP-dependent protein kinase activity | 3 | 1.72 | -1.04 | 1.4 | -1.32 | 1.33 | 4.14 | 1.26 |
cGMP-dependent protein kinase activity | 3 | -1.85 | -1.05 | 1.07 | 1.01 | 1.09 | 1.46 | 1.42 |
protein kinase C activity | 7 | 1.66 | -1.04 | 1.77 | -1.14 | 1.06 | 2.51 | 1.12 |
calcium-dependent protein kinase C activity | 3 | 1.12 | 1.04 | 2.13 | -1.07 | 1.01 | 3.21 | -1.04 |
G-protein coupled receptor kinase activity | 3 | 1.16 | 1.4 | 1.53 | 1.09 | 1.29 | 1.52 | 1.29 |
JUN kinase activity | 2 | -1.09 | 1.03 | 1.52 | 1.15 | 1.41 | -1.08 | 1.01 |
JUN kinase kinase kinase activity | 2 | 1.23 | 1.27 | 1.56 | 1.2 | 1.54 | 1.23 | 1.3 |
MAP kinase kinase kinase activity | 5 | -1.39 | 1.21 | 1.48 | 1.15 | 1.82 | 1.09 | 1.04 |
MAPK/ERK kinase kinase activity | 1 | 1.83 | 1.46 | 1.17 | -1.02 | 1.24 | 1.79 | 1.33 |
ribosomal protein S6 kinase activity | 1 | -2.62 | 1.78 | 1.7 | 1.33 | 1.66 | 1.52 | 1.3 |
transmembrane receptor protein tyrosine kinase activity | 21 | 1.55 | -1.07 | 1.14 | -1.01 | 1.13 | 1.58 | 1.42 |
non-membrane spanning protein tyrosine kinase activity | 7 | 1.37 | 1.16 | 1.77 | 1.12 | 1.46 | 1.64 | 1.42 |
protein-L-isoaspartate (D-aspartate) O-methyltransferase activity | 1 | 2.93 | 1.03 | 1.2 | 1.19 | 1.05 | 1.97 | 1.02 |
calcium-dependent protein serine/threonine phosphatase activity | 6 | 1.52 | -1.02 | 1.2 | 1.05 | 1.13 | 1.24 | 1.06 |
prenylated protein tyrosine phosphatase activity | 1 | 1.54 | 1.27 | 2.19 | -1.23 | 1.74 | 3.0 | 1.51 |
receptor signaling protein tyrosine phosphatase activity | 3 | 2.8 | -1.06 | 1.33 | -1.06 | 1.35 | 3.49 | 1.47 |
pseudouridylate synthase activity | 3 | 1.57 | 1.31 | 1.17 | 1.55 | 1.45 | 1.03 | 1.08 |
pyridoxamine-phosphate oxidase activity | 3 | 1.93 | 1.06 | -1.17 | 1.32 | 1.07 | 1.07 | -1.07 |
pyrroline-5-carboxylate reductase activity | 2 | -1.77 | 1.27 | -1.94 | 1.07 | -1.03 | -1.14 | -1.01 |
pyruvate carboxylase activity | 1 | 2.41 | -1.07 | -1.67 | 1.11 | -2.11 | 1.65 | 1.08 |
pyruvate dehydrogenase activity | 3 | -1.02 | 1.01 | 1.31 | 1.1 | -1.0 | 1.57 | -1.25 |
pyruvate dehydrogenase (acetyl-transferring) activity | 3 | -1.02 | 1.01 | 1.31 | 1.1 | -1.0 | 1.57 | -1.25 |
pyruvate dehydrogenase (acetyl-transferring) kinase activity | 1 | 1.67 | -1.54 | 1.2 | -1.13 | 7.02 | 3.44 | 1.09 |
[pyruvate dehydrogenase (lipoamide)] phosphatase activity | 1 | 1.78 | 1.13 | 1.46 | 1.23 | 1.08 | 1.92 | 1.02 |
dihydrolipoyllysine-residue acetyltransferase activity | 1 | 1.23 | 1.19 | 1.96 | -1.07 | 1.35 | 3.33 | 1.11 |
ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor | 2 | -2.27 | -1.06 | 1.44 | 1.36 | 1.87 | -1.61 | -1.54 |
ribose phosphate diphosphokinase activity | 2 | 2.41 | 1.04 | 1.7 | -1.06 | 1.1 | 2.9 | 1.34 |
ribulose-phosphate 3-epimerase activity | 1 | 3.69 | 1.12 | -1.44 | 1.15 | 1.15 | 1.38 | 1.6 |
ribose-5-phosphate isomerase activity | 1 | 2.8 | 1.42 | -1.73 | 1.16 | 1.1 | 1.26 | 1.25 |
saccharopine dehydrogenase activity | 1 | 1.21 | 1.36 | -1.07 | 1.24 | -1.06 | 1.55 | 1.4 |
saccharopine dehydrogenase (NAD+, L-lysine-forming) activity | 1 | 1.21 | 1.36 | -1.07 | 1.24 | -1.06 | 1.55 | 1.4 |
selenide, water dikinase activity | 2 | 1.76 | 1.25 | 1.23 | 1.04 | 1.04 | 1.62 | -1.07 |
sepiapterin reductase activity | 3 | 2.14 | -1.76 | -1.79 | -1.65 | -1.36 | 2.93 | -1.29 |
serine C-palmitoyltransferase activity | 2 | -2.24 | 1.07 | 2.48 | 1.17 | 1.31 | -1.71 | -1.18 |
serine-pyruvate transaminase activity | 1 | 1.1 | -1.81 | -2.08 | -1.81 | -1.6 | 3.21 | -1.83 |
sphingomyelin phosphodiesterase activity | 5 | -5.07 | -3.51 | -4.56 | 1.49 | -1.12 | -3.62 | -4.08 |
stearoyl-CoA 9-desaturase activity | 7 | -1.4 | 1.15 | -1.2 | 1.26 | 1.01 | -1.67 | -1.18 |
sterol esterase activity | 1 | -139.1 | -18.6 | -1.99 | 2.08 | -24.32 | -152.96 | -197.4 |
sterol O-acyltransferase activity | 3 | -2.3 | -1.64 | -1.24 | 1.46 | 1.26 | -1.59 | -2.16 |
succinate-semialdehyde dehydrogenase activity | 1 | -2.19 | 1.37 | 2.06 | 1.34 | 1.0 | 1.58 | -1.11 |
sulfate adenylyltransferase activity | 1 | -2.63 | 1.06 | 1.41 | 1.07 | 1.11 | -1.64 | -1.02 |
sulfate adenylyltransferase (ATP) activity | 1 | -2.63 | 1.06 | 1.41 | 1.07 | 1.11 | -1.64 | -1.02 |
sulfinoalanine decarboxylase activity | 1 | -1.56 | 1.66 | -7.28 | 1.14 | -1.03 | -3.47 | 1.18 |
thiosulfate sulfurtransferase activity | 1 | 1.15 | -1.38 | 2.62 | 1.38 | 1.04 | -1.42 | -1.83 |
threonine aldolase activity | 1 | 1.44 | -1.1 | -1.93 | 1.6 | -1.06 | 1.8 | -2.26 |
L-threonine ammonia-lyase activity | 1 | -3.81 | -2.74 | -2.14 | -1.15 | 11.07 | -1.69 | -3.46 |
thymidylate kinase activity | 1 | 1.27 | 1.13 | 1.91 | 1.21 | 1.41 | -1.17 | -1.08 |
thymidylate synthase activity | 1 | -1.63 | -1.08 | 1.19 | 1.46 | 1.72 | -2.2 | -2.17 |
sedoheptulose-7-phosphate:D-glyceraldehyde-3-phosphate glyceronetransferase activity | 1 | 3.18 | 1.11 | -3.27 | 1.02 | -1.44 | -1.1 | 1.46 |
transketolase activity | 2 | 2.03 | 1.17 | -1.56 | 1.02 | 1.12 | 1.44 | 1.62 |
trehalose-phosphatase activity | 2 | 5.88 | -2.14 | -1.49 | -1.62 | 1.02 | 4.6 | 1.12 |
triglyceride lipase activity | 38 | -3.83 | -1.33 | -1.88 | -1.09 | -1.77 | -4.41 | -2.22 |
aspartate-tRNA ligase activity | 1 | -1.97 | 1.61 | 1.28 | -1.18 | 1.45 | -1.88 | 1.38 |
cysteine-tRNA ligase activity | 2 | -1.01 | 1.37 | 1.43 | 1.08 | 1.22 | 1.24 | 1.76 |
histidine-tRNA ligase activity | 1 | -1.32 | 1.37 | -1.07 | 1.31 | -1.14 | -1.74 | -1.19 |
isoleucine-tRNA ligase activity | 2 | 1.35 | 1.22 | 1.54 | 1.02 | 1.38 | 1.61 | 1.38 |
methionine-tRNA ligase activity | 2 | -1.59 | 1.18 | 1.28 | 1.38 | 1.17 | -1.27 | -1.03 |
threonine-tRNA ligase activity | 2 | -1.65 | 1.24 | 1.06 | 1.13 | -1.08 | -1.17 | 1.02 |
valine-tRNA ligase activity | 2 | -1.62 | 1.31 | 1.29 | 1.15 | 1.04 | -1.25 | 1.17 |
tryptophan 2,3-dioxygenase activity | 1 | 1.33 | -1.46 | -1.36 | -1.56 | -1.39 | 2.84 | -1.33 |
tyrosine decarboxylase activity | 2 | 2.12 | -1.17 | -1.18 | -1.17 | 1.11 | 1.9 | -1.07 |
ubiquitin activating enzyme activity | 3 | 1.07 | 1.19 | 1.42 | 1.25 | 1.55 | 1.31 | 1.05 |
ubiquitin-specific protease activity | 8 | 1.17 | 1.21 | 1.8 | 1.18 | 1.58 | 1.96 | 1.41 |
uracil DNA N-glycosylase activity | 2 | 2.91 | -1.23 | -1.13 | -1.34 | 1.04 | 2.88 | 1.17 |
uracil phosphoribosyltransferase activity | 1 | 1.85 | 1.12 | 1.41 | 1.03 | 1.01 | 1.67 | 1.33 |
urate oxidase activity | 1 | 3.87 | -2.08 | -2.11 | -2.0 | -1.26 | -1.05 | -1.64 |
uridine kinase activity | 2 | 4.18 | -1.72 | 1.72 | -1.65 | -1.27 | 3.76 | 1.43 |
uridine phosphorylase activity | 3 | -2.2 | -1.73 | 1.35 | -1.47 | -1.37 | -2.19 | 1.39 |
uroporphyrinogen decarboxylase activity | 1 | 2.27 | -1.08 | -1.25 | 1.43 | 1.04 | 1.18 | 1.26 |
xanthine dehydrogenase activity | 2 | 1.25 | 1.78 | -1.17 | -1.32 | -1.19 | -1.3 | 1.66 |
xanthine oxidase activity | 1 | 1.38 | 1.39 | -1.09 | 1.59 | 1.39 | -1.89 | 1.34 |
cyclin-dependent protein kinase inhibitor activity | 2 | 1.97 | -1.0 | 1.05 | 1.02 | 1.15 | 1.58 | 1.04 |
protein phosphatase inhibitor activity | 7 | 1.59 | -1.08 | -1.01 | -1.03 | 1.27 | 1.27 | -1.01 |
protein serine/threonine phosphatase inhibitor activity | 1 | 1.57 | 1.1 | -1.11 | 1.22 | 1.13 | -1.01 | -1.25 |
endopeptidase inhibitor activity | 73 | 1.41 | -1.48 | -1.45 | -1.49 | -1.3 | 1.51 | 1.04 |
serine-type endopeptidase inhibitor activity | 58 | 1.2 | -1.48 | -1.57 | -1.54 | -1.37 | 1.38 | -1.05 |
cysteine-type endopeptidase inhibitor activity | 6 | 3.11 | -1.78 | -1.05 | -1.54 | -1.18 | 1.44 | 1.41 |
carbohydrate binding | 166 | -1.92 | -1.36 | -1.53 | -1.23 | -1.33 | -1.85 | -1.01 |
boss receptor activity | 1 | 2.09 | -1.24 | -1.34 | -1.08 | -1.33 | -1.62 | 1.07 |
Wnt-activated receptor activity | 5 | 1.17 | 1.03 | 1.52 | -1.14 | 1.66 | -1.04 | 1.31 |
Wnt receptor signaling pathway, calcium modulating pathway | 2 | 1.15 | 1.15 | 1.16 | 1.02 | 1.3 | 1.14 | 2.54 |
calcitonin receptor activity | 5 | 1.36 | -1.25 | 1.11 | -1.21 | 1.02 | -1.07 | 1.56 |
N-methyl-D-aspartate selective glutamate receptor activity | 5 | -2.2 | 1.03 | -1.01 | -1.04 | -1.02 | -1.52 | 1.05 |
neuropeptide Y receptor activity | 6 | -1.12 | -1.28 | 1.15 | -1.08 | 1.23 | 2.07 | -1.01 |
tachykinin receptor activity | 6 | -1.02 | -1.12 | 1.07 | -1.2 | -1.05 | 1.79 | 1.44 |
transmembrane receptor protein tyrosine phosphatase activity | 6 | 1.57 | 1.05 | 1.23 | 1.03 | 1.35 | 2.22 | 1.25 |
ephrin receptor activity | 1 | 2.31 | 1.1 | 1.68 | 1.08 | 2.32 | 2.06 | 2.34 |
epidermal growth factor-activated receptor activity | 1 | 2.54 | -1.11 | -1.09 | 1.14 | 1.59 | 3.23 | 1.89 |
fibroblast growth factor-activated receptor activity | 3 | 1.8 | -1.38 | 2.01 | 1.04 | -1.27 | -1.03 | -1.21 |
insulin-activated receptor activity | 1 | 1.01 | 1.43 | 1.57 | 1.5 | 2.27 | 1.72 | 1.64 |
insulin-like growth factor-activated receptor activity | 2 | -1.08 | -1.38 | -1.23 | -1.3 | -1.24 | 5.4 | 3.24 |
growth factor binding | 5 | -1.0 | 1.2 | 1.22 | 1.22 | 1.63 | 1.18 | 1.29 |
transforming growth factor beta-activated receptor activity | 5 | -1.03 | 1.52 | 1.48 | 1.18 | 1.61 | 1.07 | 1.49 |
transforming growth factor beta receptor activity, type I | 3 | -1.44 | 1.44 | 1.63 | 1.24 | 1.98 | 1.37 | 1.58 |
transforming growth factor beta receptor activity, type II | 2 | 1.6 | 1.65 | 1.28 | 1.09 | 1.17 | -1.35 | 1.36 |
tumor necrosis factor-activated receptor activity | 1 | 10.08 | -2.23 | 1.27 | -2.86 | -1.97 | 3.13 | 1.07 |
osmosensor activity | 1 | -6.38 | -3.77 | -11.1 | -5.2 | -1.19 | 28.07 | -1.66 |
death receptor activity | 1 | 10.08 | -2.23 | 1.27 | -2.86 | -1.97 | 3.13 | 1.07 |
death receptor binding | 1 | 1.78 | 1.11 | 1.56 | 1.24 | 1.76 | -1.03 | 1.11 |
netrin receptor activity | 2 | -1.2 | 1.24 | 1.26 | 1.34 | 2.11 | -1.46 | 1.04 |
KDEL sequence binding | 1 | -1.48 | 1.27 | 1.01 | 1.14 | -1.01 | -1.37 | 1.53 |
nuclear export signal receptor activity | 3 | 1.18 | 1.05 | 2.95 | 1.07 | 1.92 | 2.19 | 1.34 |
peroxisome | 39 | 1.3 | -1.06 | -1.53 | 1.05 | 1.16 | -1.5 | -1.16 |
peroxisomal membrane | 14 | 1.87 | 1.14 | -1.32 | 1.28 | 1.36 | -1.33 | -1.09 |
laminin receptor activity | 1 | -9.63 | 1.35 | 1.66 | 1.05 | 1.52 | -7.44 | 1.13 |
transforming growth factor beta receptor, cytoplasmic mediator activity | 4 | 1.26 | 1.21 | 1.59 | 1.07 | 1.32 | 1.36 | 1.28 |
transforming growth factor beta receptor, inhibitory cytoplasmic mediator activity | 1 | 2.8 | 1.17 | 2.77 | -1.14 | 1.51 | 2.43 | 1.42 |
transforming growth factor beta receptor, pathway-specific cytoplasmic mediator activity | 1 | -2.15 | 1.12 | -1.08 | 1.29 | -1.07 | -2.29 | 1.33 |
protein kinase A binding | 3 | -1.23 | 1.19 | 1.19 | 1.03 | 1.27 | 1.0 | 1.5 |
protein kinase C binding | 5 | 1.76 | 1.33 | 1.56 | 1.07 | 1.48 | 1.92 | 1.83 |
guanyl-nucleotide exchange factor activity | 52 | 1.11 | 1.15 | 1.38 | 1.01 | 1.29 | 1.52 | 1.26 |
ARF guanyl-nucleotide exchange factor activity | 6 | -1.22 | 1.21 | 1.27 | -1.01 | 1.25 | 1.49 | 1.58 |
GDP-dissociation inhibitor activity | 2 | -1.01 | -1.04 | 1.34 | 1.09 | 1.21 | -1.08 | -1.54 |
Rho GDP-dissociation inhibitor activity | 1 | -1.46 | -1.08 | 1.63 | 1.09 | 1.3 | -1.27 | -1.71 |
Ran GTPase activator activity | 1 | 1.34 | 1.36 | 1.62 | 1.42 | 1.91 | 1.35 | 1.2 |
fibroblast growth factor receptor binding | 3 | 1.57 | 1.01 | 2.07 | -1.12 | 1.29 | 2.72 | 1.05 |
ephrin receptor binding | 1 | 1.81 | 1.29 | 1.78 | 1.1 | 1.94 | 2.77 | 1.53 |
anchored to plasma membrane | 3 | 3.1 | -2.01 | -3.22 | -2.43 | -1.37 | 2.44 | 1.37 |
frizzled binding | 3 | -1.65 | -1.07 | 1.18 | -1.29 | 1.31 | 1.28 | 1.51 |
frizzled-2 binding | 2 | -1.8 | 1.01 | 1.43 | -1.3 | -1.11 | 1.61 | 2.1 |
patched binding | 2 | -1.41 | -1.16 | 1.11 | 1.42 | 1.34 | -1.32 | -2.31 |
sevenless binding | 2 | 2.05 | 1.08 | 1.52 | 1.1 | 1.59 | 1.98 | 1.31 |
smoothened binding | 1 | 1.33 | 1.48 | 1.27 | 1.38 | 1.17 | 1.23 | 1.56 |
Toll binding | 6 | 2.0 | -1.13 | -1.18 | -1.1 | -1.05 | 3.64 | 1.27 |
torso binding | 2 | 4.82 | -2.22 | -1.24 | -1.06 | 1.12 | 2.59 | 1.13 |
cytokine activity | 3 | 2.09 | -1.14 | -1.06 | -1.07 | 1.06 | 1.89 | 1.58 |
epidermal growth factor receptor binding | 8 | 2.02 | -1.02 | 1.33 | 1.03 | 1.43 | 2.13 | 1.51 |
positive regulation of epidermal growth factor-activated receptor activity | 1 | -1.21 | 1.16 | 2.16 | -1.11 | 1.4 | 1.68 | 1.37 |
insulin-like growth factor receptor binding | 1 | 2.22 | 1.3 | 2.31 | -1.1 | 1.87 | 2.8 | 1.91 |
transforming growth factor beta receptor binding | 7 | 1.67 | 1.01 | -1.0 | -1.48 | -1.16 | 1.33 | 1.27 |
tumor necrosis factor receptor binding | 1 | 1.09 | -1.11 | -1.93 | -1.35 | 4.12 | -1.38 | 6.18 |
hormone activity | 52 | -1.48 | -1.33 | -1.19 | -1.09 | -1.16 | -1.59 | -1.16 |
neuropeptide hormone activity | 35 | -1.76 | -1.5 | -1.27 | -1.18 | -1.19 | -1.89 | -1.23 |
structural constituent of cell wall | 2 | 4.29 | -1.81 | -1.38 | -1.64 | -1.67 | 1.06 | 1.01 |
collagen | 3 | 1.14 | -1.43 | 1.08 | -1.25 | -1.21 | 1.82 | -1.14 |
structural constituent of eye lens | 1 | -23.09 | -8.59 | -4.86 | 2.62 | -1.02 | -36.83 | -31.54 |
intracellular ligand-gated ion channel activity | 7 | 1.42 | 1.03 | 1.28 | 1.0 | 1.1 | 1.59 | 1.16 |
intracellular ligand-gated calcium channel activity | 3 | 1.97 | -1.03 | 1.18 | 1.08 | 1.09 | 1.76 | 1.17 |
ryanodine-sensitive calcium-release channel activity | 1 | 3.82 | -1.03 | 1.3 | -1.12 | 1.16 | 2.73 | 1.18 |
inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity | 1 | 2.52 | 1.29 | 3.07 | -1.16 | 1.37 | 5.13 | 2.97 |
volume-sensitive anion channel activity | 2 | 1.92 | 1.08 | -1.06 | -1.08 | 2.11 | 2.25 | 1.09 |
calcium activated cation channel activity | 3 | -1.25 | -1.55 | 1.25 | 1.49 | -1.39 | -1.46 | -1.49 |
inhibitory extracellular ligand-gated ion channel activity | 4 | -1.54 | 1.26 | 1.47 | -1.43 | -1.72 | -1.63 | -1.04 |
inward rectifier potassium channel activity | 4 | -1.18 | -1.13 | -1.58 | -3.21 | -3.46 | 1.87 | -1.7 |
gap junction channel activity | 6 | -1.73 | -1.09 | -1.05 | -1.09 | -1.25 | -1.21 | 1.35 |
voltage-gated chloride channel activity | 3 | -1.31 | 1.23 | -1.16 | 1.19 | 1.05 | 1.88 | 1.52 |
A-type (transient outward) potassium channel activity | 2 | 3.38 | -1.08 | 1.04 | -1.08 | 1.22 | 1.8 | -1.38 |
open rectifier potassium channel activity | 3 | 2.34 | -1.1 | -1.13 | -1.16 | 1.03 | 1.04 | -1.38 |
amine transmembrane transporter activity | 58 | -1.3 | -1.08 | -1.61 | -1.23 | -1.04 | -1.08 | -1.11 |
hydrogen:amino acid symporter activity | 2 | 1.74 | 1.43 | -1.72 | -1.09 | 1.17 | -1.0 | 1.38 |
amino acid transmembrane transporter activity | 53 | -1.39 | -1.07 | -1.67 | -1.24 | -1.03 | -1.11 | -1.1 |
L-tyrosine transmembrane transporter activity | 2 | 3.0 | -1.1 | 1.15 | -1.28 | -1.42 | 2.49 | 1.13 |
organic acid:sodium symporter activity | 8 | -1.17 | 1.19 | -1.85 | -1.42 | -1.96 | -1.64 | 1.15 |
L-glutamate transmembrane transporter activity | 4 | -2.07 | 1.33 | -5.17 | -2.48 | -1.62 | -1.72 | -2.15 |
high-affinity glutamate transmembrane transporter activity | 1 | -51.3 | 1.56 | -15.93 | -1.24 | 2.78 | -3.27 | -134.18 |
inorganic phosphate transmembrane transporter activity | 3 | 2.26 | -1.45 | 1.37 | -1.34 | 1.47 | 3.74 | -1.03 |
high affinity inorganic phosphate:sodium symporter activity | 18 | -3.67 | 1.02 | -3.81 | -1.03 | -1.98 | -1.81 | -2.84 |
neurotransmitter transporter activity | 24 | 1.11 | -1.3 | -1.53 | -1.28 | 1.11 | 1.77 | 1.29 |
neurotransmitter:sodium symporter activity | 18 | 1.0 | -1.4 | -1.72 | -1.34 | 1.19 | 1.93 | 1.23 |
sugar:hydrogen symporter activity | 8 | 1.06 | -1.15 | -1.17 | -1.12 | -1.18 | -1.05 | 1.82 |
glucose transmembrane transporter activity | 15 | -1.29 | -1.15 | -1.91 | -1.13 | -1.42 | -1.88 | 1.23 |
tricarboxylate secondary active transmembrane transporter activity | 3 | -1.58 | 1.64 | -1.92 | -1.18 | -1.42 | 1.07 | 1.16 |
water transmembrane transporter activity | 7 | -2.13 | 1.26 | -1.34 | -1.07 | -2.07 | -2.5 | -1.23 |
secondary active transmembrane transporter activity | 155 | -1.44 | -1.11 | -1.62 | -1.18 | -1.13 | 1.21 | -1.17 |
manganese ion transmembrane transporter activity | 2 | -1.53 | 1.28 | -1.11 | 1.02 | -1.23 | -1.54 | 1.12 |
sodium:potassium-exchanging ATPase activity | 8 | 1.13 | -1.11 | 1.22 | -1.35 | -1.0 | 1.53 | 1.06 |
cation:sugar symporter activity | 8 | 1.06 | -1.15 | -1.17 | -1.12 | -1.18 | -1.05 | 1.82 |
nucleoside:sodium symporter activity | 2 | -7.59 | 1.47 | -2.97 | -1.0 | -2.3 | -5.85 | -2.0 |
cation:amino acid symporter activity | 13 | 1.13 | -1.27 | -2.32 | -1.57 | 1.11 | 1.18 | 1.23 |
proton-dependent oligopeptide secondary active transmembrane transporter activity | 3 | 1.69 | -1.17 | -1.51 | -1.15 | -1.07 | 1.17 | 1.2 |
synaptic vesicle amine transmembrane transporter activity | 1 | 9.63 | -2.21 | -1.97 | -1.79 | -1.94 | -1.46 | -1.99 |
calcium:sodium antiporter activity | 2 | -1.37 | 1.7 | 1.3 | -1.23 | 1.65 | 2.01 | 1.96 |
sodium:phosphate symporter activity | 21 | -3.19 | 1.03 | -3.12 | -1.03 | -1.89 | -1.53 | -2.45 |
monovalent cation:hydrogen antiporter activity | 4 | -2.37 | -1.01 | -1.35 | 1.01 | -1.74 | 3.33 | -1.27 |
inorganic anion exchanger activity | 2 | -3.68 | -3.74 | 3.73 | -4.0 | -1.27 | -1.18 | -1.53 |
CMP-N-acetylneuraminate transmembrane transporter activity | 3 | -1.73 | 1.25 | -1.03 | 1.28 | -1.06 | -1.84 | 1.23 |
UDP-galactose transmembrane transporter activity | 6 | -1.21 | 1.24 | 1.0 | 1.15 | 1.18 | -1.35 | 1.53 |
UDP-glucuronic acid transmembrane transporter activity | 4 | -1.46 | 1.25 | 1.0 | 1.26 | 1.04 | -1.57 | 1.43 |
UDP-N-acetylgalactosamine transmembrane transporter activity | 2 | -2.31 | 1.25 | -1.08 | 1.21 | 1.09 | -2.5 | 1.48 |
UDP-xylose transmembrane transporter activity | 3 | -1.4 | 1.3 | 1.05 | 1.18 | -1.06 | -1.45 | 1.9 |
carnitine:acyl carnitine antiporter activity | 2 | 1.34 | 1.32 | -1.91 | 1.22 | 1.14 | -1.7 | -1.23 |
synaptic vesicle to endosome fusion | 1 | 1.73 | -1.06 | 2.32 | 1.09 | 1.39 | 3.26 | 1.36 |
synaptic vesicle targeting | 9 | 1.07 | 1.25 | 1.5 | 1.16 | 1.39 | 1.39 | 1.23 |
soluble NSF attachment protein activity | 6 | 1.55 | 1.06 | 1.18 | 1.07 | 1.23 | 1.28 | 1.16 |
steroid binding | 19 | -2.28 | -1.49 | -1.79 | 1.11 | -1.16 | -2.3 | -2.31 |
retinoid binding | 8 | 2.32 | -6.6 | -7.06 | -2.49 | -1.68 | 1.78 | 1.1 |
fatty acid binding | 11 | -1.61 | -1.59 | -2.07 | -1.15 | 1.3 | -1.68 | -1.56 |
copper ion binding | 20 | -1.87 | -1.23 | -1.09 | -1.21 | -1.25 | -1.59 | 1.03 |
detection of calcium ion | 3 | -1.58 | -1.06 | -1.06 | 1.03 | 1.08 | -1.26 | -1.33 |
cytoskeletal regulatory protein binding | 1 | -1.55 | 1.24 | 2.16 | 1.01 | 1.73 | 1.49 | 1.71 |
tropomyosin binding | 3 | 5.21 | -1.74 | 1.31 | -1.52 | 1.36 | 3.43 | -1.33 |
galactose binding | 11 | -1.6 | -1.21 | 1.22 | -1.04 | -1.07 | -1.49 | -1.08 |
folic acid binding | 4 | -1.96 | -1.02 | -2.85 | 1.48 | -1.35 | -1.15 | -2.07 |
phosphatidylinositol-4,5-bisphosphate binding | 2 | -1.07 | 1.2 | 1.71 | 1.09 | 1.37 | 1.09 | 1.1 |
protein tag | 2 | 2.12 | -1.08 | -1.18 | 1.19 | 1.03 | -1.14 | 1.1 |
collagen type IV | 2 | 1.15 | -1.7 | -1.07 | -1.48 | -1.42 | 2.42 | -1.33 |
basement membrane | 10 | 1.55 | -1.19 | 1.13 | -1.32 | 1.1 | 2.13 | 1.42 |
basal lamina | 3 | 2.42 | -1.01 | 1.11 | -1.14 | 1.47 | 4.1 | 1.43 |
laminin-1 complex | 1 | 3.52 | 1.3 | 1.81 | 1.23 | 2.46 | 6.46 | 1.6 |
integrin complex | 8 | -1.75 | 1.03 | 1.23 | -1.07 | 1.36 | -1.33 | 1.18 |
interstitial matrix | 1 | -3.11 | 1.08 | 3.33 | -1.03 | 2.28 | -1.55 | -1.14 |
nuclear inner membrane | 7 | 1.5 | -1.14 | 1.37 | 1.22 | 1.72 | 1.02 | -1.06 |
integral to nuclear inner membrane | 2 | -1.02 | -2.05 | 1.59 | 1.21 | 2.03 | -1.95 | -2.17 |
nuclear outer membrane | 1 | 2.5 | -1.28 | -1.45 | -1.24 | 1.61 | 3.68 | 4.91 |
nuclear envelope lumen | 2 | 1.16 | 1.03 | 1.1 | 1.15 | 1.11 | 1.57 | -1.14 |
Ran GTPase binding | 7 | -1.02 | 1.21 | 1.82 | 1.21 | 1.53 | 1.48 | 1.33 |
nucleolar ribonuclease P complex | 1 | 1.84 | 1.03 | 1.1 | 1.42 | 1.17 | 1.05 | -1.14 |
pre-replicative complex | 9 | -1.14 | 1.11 | 1.17 | 1.27 | 1.56 | -1.1 | -1.11 |
DNA replication factor C complex | 5 | 1.37 | 1.06 | 1.26 | 1.45 | 1.6 | 1.11 | -1.08 |
PCNA complex | 2 | -1.29 | 1.09 | 1.33 | 1.22 | 1.3 | -1.6 | -1.28 |
DNA replication factor A complex | 3 | 1.13 | 1.13 | 1.31 | 1.42 | 1.65 | 1.03 | -1.21 |
transcription factor TFIIE complex | 2 | 1.86 | 1.06 | 1.16 | 1.23 | 1.25 | 1.2 | 1.16 |
chromatin assembly complex | 8 | 1.08 | -1.4 | -1.04 | -1.4 | 1.24 | 1.6 | 1.04 |
U12 snRNP | 1 | 1.7 | -1.05 | -1.07 | -1.09 | -1.18 | 1.33 | 1.14 |
nuclear euchromatin | 4 | 1.52 | 1.39 | 1.51 | 1.2 | 1.41 | 1.55 | 1.43 |
beta-heterochromatin | 1 | 1.4 | 1.27 | 1.49 | -1.01 | 1.2 | 1.7 | 1.58 |
nuclear telomeric heterochromatin | 1 | -1.17 | 1.26 | 1.25 | 1.08 | 2.11 | -1.1 | 1.25 |
mitochondrial respiratory chain | 68 | 1.11 | 1.0 | 1.19 | 1.01 | 1.07 | 1.57 | -1.31 |
mitochondrial respiratory chain complex I | 37 | 1.15 | 1.04 | 1.27 | 1.07 | 1.11 | 1.72 | -1.29 |
mitochondrial proton-transporting ATP synthase complex | 18 | 1.31 | -1.01 | 1.22 | -1.03 | 1.11 | 1.68 | -1.22 |
proton-transporting ATP synthase complex, coupling factor F(o) | 9 | 1.19 | 1.04 | 1.31 | 1.01 | 1.22 | 1.62 | -1.14 |
mitochondrial proton-transporting ATP synthase, central stalk | 1 | 1.03 | 1.03 | 1.17 | 1.01 | 1.11 | 1.58 | -1.38 |
mitochondrial ribosome | 72 | 1.04 | 1.07 | 1.23 | 1.29 | 1.25 | 1.45 | -1.55 |
mitochondrial large ribosomal subunit | 44 | 1.03 | 1.05 | 1.24 | 1.3 | 1.28 | 1.46 | -1.6 |
lysosomal membrane | 4 | 1.09 | -1.11 | -1.38 | 1.13 | 1.63 | 2.55 | 1.04 |
secondary lysosome | 1 | 1.17 | -2.03 | 2.67 | -1.12 | -2.24 | 1.02 | -1.06 |
multivesicular body | 6 | -1.01 | 1.0 | 1.49 | 1.07 | 1.26 | 1.31 | 1.59 |
vacuolar membrane | 30 | -1.55 | -1.0 | 1.28 | -1.14 | -1.08 | 1.41 | -1.12 |
integral to peroxisomal membrane | 5 | 1.37 | 1.29 | -1.51 | 1.15 | 1.08 | -1.33 | -1.13 |
protein targeting to peroxisome | 3 | 1.5 | 1.17 | -1.6 | 1.44 | 1.46 | -2.19 | -1.64 |
peroxisomal part | 14 | 1.87 | 1.14 | -1.32 | 1.28 | 1.36 | -1.33 | -1.09 |
Sec61 translocon complex | 8 | -1.51 | 1.3 | -1.14 | -1.0 | -1.28 | -1.7 | 1.22 |
signal recognition particle receptor complex | 4 | -1.91 | 1.42 | -1.08 | 1.06 | -1.35 | -1.79 | 1.42 |
signal recognition particle, endoplasmic reticulum targeting | 9 | -1.25 | 1.37 | 1.01 | 1.14 | -1.09 | -1.57 | 1.26 |
signal peptidase complex | 3 | 1.12 | -1.0 | 1.0 | -1.02 | -1.02 | -1.01 | 1.75 |
smooth endoplasmic reticulum | 5 | 2.12 | -1.15 | 1.68 | -1.13 | 1.04 | 1.12 | 1.23 |
rough endoplasmic reticulum | 15 | -1.44 | 1.23 | -1.0 | 1.01 | -1.26 | -1.5 | 1.29 |
endoplasmic reticulum-Golgi intermediate compartment | 1 | -1.08 | 1.49 | -1.64 | 1.02 | -1.4 | -2.11 | -1.11 |
ER to Golgi transport vesicle | 4 | 1.31 | 1.22 | 1.29 | 1.04 | 1.28 | 1.43 | 2.03 |
trans-Golgi network | 6 | -1.72 | 1.13 | 1.32 | 1.15 | 1.37 | 1.03 | 1.11 |
transport vesicle | 15 | 1.23 | 1.06 | 1.2 | -1.01 | 1.17 | 1.53 | 1.45 |
transport vesicle membrane | 4 | -1.16 | 1.25 | 1.59 | 1.05 | 1.44 | 1.76 | 1.54 |
actomyosin contractile ring | 4 | -1.06 | 1.15 | 1.51 | 1.14 | 1.77 | 1.47 | 1.16 |
polysome | 1 | 2.2 | 1.38 | 1.27 | 1.25 | 1.7 | 1.45 | 1.27 |
mRNA cap binding complex | 2 | 1.35 | 1.18 | 1.45 | 1.11 | 1.5 | 1.76 | 1.35 |
mRNA cleavage and polyadenylation specificity factor complex | 7 | 1.3 | 1.31 | 1.42 | 1.47 | 1.64 | 1.34 | 1.15 |
eukaryotic translation initiation factor 3 complex | 16 | 1.44 | 1.14 | 1.33 | 1.03 | 1.2 | 1.61 | 1.17 |
eukaryotic translation elongation factor 1 complex | 5 | 2.72 | -1.02 | 1.29 | -1.13 | 1.23 | 1.37 | 1.32 |
nascent polypeptide-associated complex | 3 | 1.55 | -1.11 | 1.12 | 1.0 | 1.05 | 1.16 | 1.07 |
muscle myosin complex | 5 | 4.08 | -1.62 | 1.08 | -1.52 | 1.03 | 2.86 | -1.26 |
troponin complex | 2 | 6.95 | -2.33 | -1.12 | -1.86 | 1.08 | 3.33 | -1.76 |
muscle thin filament tropomyosin | 2 | 3.23 | -1.38 | 1.31 | -1.15 | 1.21 | 2.24 | -1.26 |
striated muscle myosin thick filament | 3 | 2.91 | -1.49 | 1.05 | -1.32 | 1.04 | 2.39 | -1.29 |
striated muscle thin filament | 5 | 3.24 | -1.5 | 1.09 | -1.38 | 1.25 | 2.3 | -1.28 |
nuclear microtubule | 1 | 1.51 | 1.15 | 1.47 | 1.1 | 1.35 | 1.02 | -1.14 |
Arp2/3 protein complex | 5 | -3.04 | -1.69 | -1.35 | 1.45 | 1.29 | -2.9 | -1.36 |
sodium:potassium-exchanging ATPase complex | 8 | 1.13 | -1.11 | 1.22 | -1.35 | -1.0 | 1.53 | 1.06 |
insulin receptor complex | 1 | 1.01 | 1.43 | 1.57 | 1.5 | 2.27 | 1.72 | 1.64 |
caveola | 1 | 3.68 | -1.06 | -1.03 | 1.16 | 1.0 | 1.99 | -1.04 |
microvillus | 5 | 1.36 | 1.2 | 1.61 | -1.02 | 1.17 | 1.09 | 1.29 |
brush border | 3 | -22.7 | -1.04 | -2.81 | 1.01 | -1.94 | 1.91 | -2.7 |
cell-cell junction | 66 | 1.52 | -1.07 | 1.19 | -1.11 | 1.18 | 1.85 | 1.41 |
cell-cell adherens junction | 13 | 1.51 | 1.27 | 1.67 | 1.06 | 1.61 | 1.75 | 1.74 |
spot adherens junction | 4 | 1.12 | 1.24 | 1.44 | 1.07 | 1.52 | 1.53 | 1.48 |
zonula adherens | 9 | 1.2 | 1.26 | 1.62 | 1.08 | 1.63 | 1.49 | 1.6 |
nephrocyte diaphragm | 3 | -3.44 | 1.01 | 1.01 | 1.15 | 1.01 | -2.84 | -1.29 |
septate junction | 22 | 2.96 | -1.28 | 1.21 | -1.34 | 1.26 | 3.68 | 1.76 |
pleated septate junction | 3 | 3.11 | -1.4 | 1.27 | -1.39 | 1.24 | 4.46 | 1.69 |
gap junction | 8 | -1.22 | -1.27 | -1.23 | -1.25 | -1.39 | 1.09 | 1.54 |
tight junction | 4 | 1.14 | 1.05 | 1.46 | 1.03 | 1.1 | 1.55 | 1.04 |
connecting hemi-adherens junction | 1 | 1.1 | 1.42 | 2.42 | 1.36 | 2.63 | 2.12 | 3.14 |
muscle tendon junction | 5 | 2.04 | -1.05 | 1.1 | -1.07 | -1.09 | 1.36 | 1.08 |
septin ring | 5 | -1.56 | 1.08 | 1.09 | 1.16 | 1.34 | -1.29 | 1.06 |
phosphatidylinositol 3-kinase complex | 4 | -1.6 | 1.29 | 1.4 | 1.19 | 1.74 | -1.12 | -1.04 |
1-phosphatidylinositol-4-phosphate 3-kinase, class IA complex | 2 | -1.54 | 1.47 | 1.35 | 1.15 | 1.83 | 1.07 | 1.48 |
6-phosphofructokinase complex | 1 | 2.63 | -1.22 | -1.22 | 1.02 | -1.12 | 5.11 | 1.3 |
mitochondrial alpha-ketoglutarate dehydrogenase complex | 1 | -1.4 | -1.14 | 2.27 | -1.25 | -1.48 | 1.94 | -1.5 |
cAMP-dependent protein kinase complex | 6 | 1.3 | 1.06 | 1.3 | -1.12 | 1.18 | 1.98 | 1.03 |
calcium- and calmodulin-dependent protein kinase complex | 2 | 1.81 | 1.24 | 1.48 | 1.18 | 1.44 | 2.31 | 1.51 |
calcineurin complex | 5 | 1.63 | -1.01 | 1.24 | 1.04 | 1.14 | 1.3 | 1.06 |
DNA-dependent protein kinase-DNA ligase 4 complex | 2 | -1.03 | 1.29 | 1.58 | 1.29 | 1.51 | -1.21 | 1.27 |
glycine cleavage complex | 4 | 1.1 | -1.07 | 1.31 | -1.13 | -1.08 | 2.33 | -1.17 |
mitochondrial isocitrate dehydrogenase complex (NAD+) | 1 | -1.07 | 1.16 | -1.05 | -1.13 | 1.15 | 1.71 | 1.06 |
phosphorylase kinase complex | 3 | 1.8 | 1.28 | 1.21 | 1.07 | 1.13 | 2.26 | 1.63 |
protein farnesyltransferase complex | 1 | -1.83 | -1.28 | -1.22 | 1.05 | -1.01 | -1.04 | 2.75 |
mitochondrial pyruvate dehydrogenase complex | 1 | 1.23 | 1.19 | 1.96 | -1.07 | 1.35 | 3.33 | 1.11 |
ribonucleoside-diphosphate reductase complex | 2 | -2.27 | -1.06 | 1.44 | 1.36 | 1.87 | -1.61 | -1.54 |
polysaccharide metabolic process | 131 | -1.49 | -1.56 | -1.71 | -1.43 | -1.46 | -1.36 | 1.27 |
glycogen metabolic process | 9 | 2.15 | 1.01 | -1.12 | 1.0 | 1.05 | 2.73 | 1.34 |
glycogen biosynthetic process | 5 | 2.74 | -1.19 | -1.42 | 1.04 | 1.07 | 2.78 | 1.29 |
glycogen catabolic process | 1 | 2.98 | -1.08 | 1.5 | -1.31 | 1.12 | 4.86 | 1.33 |
disaccharide metabolic process | 5 | 2.21 | -1.79 | -2.13 | -1.71 | -1.22 | 2.7 | -1.01 |
trehalose metabolic process | 5 | 2.21 | -1.79 | -2.13 | -1.71 | -1.22 | 2.7 | -1.01 |
trehalose biosynthetic process | 3 | 3.57 | -2.83 | -2.37 | -2.36 | -1.16 | 5.45 | -1.46 |
monosaccharide metabolic process | 74 | -1.39 | -1.01 | -1.54 | 1.02 | -1.04 | -1.38 | -1.41 |
fructose metabolic process | 1 | 1.09 | -1.34 | 2.59 | -1.04 | 1.14 | 3.38 | -1.06 |
fructose 2,6-bisphosphate metabolic process | 1 | 1.09 | -1.34 | 2.59 | -1.04 | 1.14 | 3.38 | -1.06 |
fucose metabolic process | 4 | -1.24 | 1.16 | -1.09 | -1.11 | 1.15 | -1.73 | 2.16 |
L-fucose biosynthetic process | 2 | -1.67 | 1.21 | 1.13 | 1.24 | 1.36 | -1.89 | -1.14 |
glucose catabolic process | 33 | 1.52 | 1.06 | -1.18 | -1.03 | -1.06 | 1.37 | 1.2 |
galactose metabolic process | 1 | -2.18 | 1.44 | -1.11 | -1.39 | 1.11 | -2.6 | 2.04 |
mannose metabolic process | 11 | -9.63 | -1.07 | -4.72 | 1.44 | -1.08 | -9.35 | -13.32 |
inositol metabolic process | 2 | 2.7 | -2.43 | -2.03 | -2.2 | -1.38 | 3.25 | -1.23 |
inositol biosynthetic process | 1 | 1.86 | -1.46 | -1.12 | -1.51 | 1.13 | 1.83 | 1.71 |
aminoglycan metabolic process | 120 | -1.64 | -1.63 | -1.78 | -1.48 | -1.53 | -1.5 | 1.27 |
aminoglycan catabolic process | 29 | -1.22 | -1.95 | -2.17 | -1.68 | -1.71 | -1.1 | 1.4 |
glycosaminoglycan catabolic process | 12 | -1.13 | -1.64 | -1.19 | -1.04 | -1.82 | -1.69 | -1.29 |
chitin metabolic process | 96 | -1.91 | -1.76 | -2.05 | -1.64 | -1.62 | -1.64 | 1.34 |
chitin biosynthetic process | 4 | 1.85 | -1.21 | -1.08 | -1.24 | -1.23 | 2.11 | 1.33 |
chitin catabolic process | 17 | -1.28 | -2.2 | -3.31 | -2.38 | -1.64 | 1.24 | 2.14 |
cuticle chitin metabolic process | 7 | -1.6 | -1.5 | -2.17 | -1.7 | -1.06 | 1.36 | 1.67 |
cuticle chitin biosynthetic process | 3 | 1.16 | -1.14 | 1.05 | -1.21 | -1.11 | 2.09 | 1.42 |
cuticle chitin catabolic process | 4 | -2.55 | -1.85 | -4.04 | -2.19 | -1.03 | -1.02 | 1.9 |
ethanol metabolic process | 2 | 1.95 | -1.28 | -2.91 | -1.89 | 1.06 | 1.72 | 1.15 |
ethanol oxidation | 2 | 1.95 | -1.28 | -2.91 | -1.89 | 1.06 | 1.72 | 1.15 |
cellular glucan metabolic process | 9 | 2.15 | 1.01 | -1.12 | 1.0 | 1.05 | 2.73 | 1.34 |
cellular aldehyde metabolic process | 8 | 1.58 | -1.07 | -1.41 | -1.33 | -1.03 | 1.21 | 1.04 |
acetyl-CoA biosynthetic process from pyruvate | 1 | 1.23 | 1.19 | 1.96 | -1.07 | 1.35 | 3.33 | 1.11 |
pyruvate metabolic process | 10 | 1.06 | 1.22 | 1.23 | -1.11 | 1.04 | 1.51 | 1.12 |
generation of precursor metabolites and energy | 140 | 1.11 | 1.05 | 1.13 | 1.0 | 1.09 | 1.53 | -1.12 |
gluconeogenesis | 4 | 1.09 | -1.28 | -1.21 | -1.39 | 1.08 | 1.63 | -1.02 |
glyoxylate cycle | 1 | 1.5 | 1.55 | -1.65 | -1.56 | -1.01 | -1.09 | 1.26 |
pentose-phosphate shunt | 7 | 2.13 | 1.17 | -1.85 | 1.03 | -1.09 | 1.03 | 1.53 |
tricarboxylic acid cycle | 36 | -1.0 | 1.09 | 1.26 | -1.05 | 1.07 | 1.52 | -1.04 |
2-oxoglutarate metabolic process | 2 | -1.13 | -1.34 | 1.15 | -1.41 | 1.89 | 2.28 | -2.14 |
fumarate metabolic process | 6 | -1.06 | -1.08 | 1.01 | -1.19 | 1.09 | 1.49 | -1.51 |
isocitrate metabolic process | 1 | 1.5 | 1.55 | -1.65 | -1.56 | -1.01 | -1.09 | 1.26 |
regulation of carbohydrate metabolic process | 3 | -1.56 | -1.05 | -1.43 | -1.32 | 1.05 | 1.6 | 2.11 |
energy reserve metabolic process | 9 | 2.15 | 1.01 | -1.12 | 1.0 | 1.05 | 2.73 | 1.34 |
NADH oxidation | 1 | -1.32 | -1.9 | 1.3 | -2.14 | 3.35 | 4.87 | -4.48 |
acetaldehyde metabolic process | 2 | 2.78 | -1.16 | -2.38 | -2.31 | -1.44 | 1.4 | 1.22 |
respiratory electron transport chain | 63 | 1.04 | 1.03 | 1.18 | 1.06 | 1.12 | 1.53 | -1.32 |
oxidative phosphorylation | 65 | 1.08 | 1.05 | 1.19 | 1.05 | 1.1 | 1.53 | -1.32 |
mitochondrial electron transport, NADH to ubiquinone | 31 | 1.15 | 1.03 | 1.29 | 1.07 | 1.13 | 1.74 | -1.29 |
mitochondrial electron transport, succinate to ubiquinone | 3 | -1.1 | 1.07 | 1.36 | -1.03 | -1.0 | 1.57 | -1.31 |
glycerophosphate shuttle | 2 | 1.11 | -1.19 | -1.41 | 1.22 | 2.52 | 1.34 | -1.21 |
glutathione metabolic process | 4 | -2.31 | 1.0 | -1.94 | 1.16 | 1.13 | -1.72 | 1.13 |
ADP biosynthetic process | 2 | -1.29 | -1.01 | -1.04 | 1.37 | 1.42 | -2.05 | -1.57 |
GMP biosynthetic process | 2 | 1.15 | 1.21 | 1.23 | -1.01 | 1.16 | 1.11 | 2.05 |
IMP biosynthetic process | 7 | 1.14 | 1.03 | -1.12 | -1.04 | -1.13 | 1.95 | -1.01 |
'de novo' IMP biosynthetic process | 6 | 1.13 | 1.02 | -1.2 | -1.03 | -1.2 | 1.78 | -1.03 |
'de novo' pyrimidine base biosynthetic process | 6 | 1.66 | -1.0 | 1.02 | -1.03 | -1.03 | 1.11 | 1.08 |
pyrimidine base catabolic process | 3 | 2.92 | -1.42 | -1.24 | -1.35 | -1.35 | 1.45 | 1.16 |
cytidine catabolic process | 3 | -2.8 | 1.04 | -1.39 | 1.2 | 1.32 | -1.87 | -1.06 |
dTDP biosynthetic process | 1 | 1.27 | 1.13 | 1.91 | 1.21 | 1.41 | -1.17 | -1.08 |
DNA ligation | 2 | 1.6 | 1.14 | 1.36 | 1.04 | 1.35 | 1.44 | 1.13 |
pre-replicative complex assembly | 7 | -1.21 | 1.08 | 1.17 | 1.27 | 1.62 | -1.3 | -1.19 |
DNA strand elongation involved in DNA replication | 3 | -1.21 | -1.08 | 1.4 | 1.14 | 1.61 | -1.08 | -1.25 |
leading strand elongation | 1 | -1.9 | -1.01 | 1.54 | 1.17 | 1.67 | -2.38 | -1.41 |
RNA-dependent DNA replication | 1 | 1.54 | 1.82 | 1.92 | -1.04 | 1.87 | 1.15 | 2.39 |
base-excision repair | 6 | 1.51 | -1.01 | 1.25 | 1.11 | 1.19 | 1.33 | -1.13 |
nucleotide-excision repair, DNA incision, 5'-to lesion | 1 | 1.98 | 1.16 | 1.33 | 1.18 | 1.39 | 1.07 | 1.02 |
DNA dealkylation involved in DNA repair | 1 | 1.12 | -1.01 | 1.19 | 1.74 | 1.2 | 1.06 | -1.09 |
DNA catabolic process | 9 | 1.71 | -1.1 | 1.05 | -1.12 | 1.18 | 1.29 | 1.41 |
DNA fragmentation involved in apoptotic nuclear change | 3 | 1.86 | 1.09 | 1.48 | 1.14 | 1.43 | 1.6 | 1.67 |
DNA replication-independent nucleosome assembly | 1 | -1.49 | 1.47 | -1.04 | 1.39 | 1.42 | -1.65 | -1.06 |
chromatin-mediated maintenance of transcription | 8 | 1.92 | 1.19 | 1.53 | 1.04 | 1.43 | 1.72 | 1.45 |
chromatin silencing at telomere | 2 | 1.51 | 1.1 | 1.54 | 1.1 | 1.65 | 2.14 | 1.15 |
regulation of transcription from RNA polymerase III promoter | 5 | 1.56 | 1.19 | 1.46 | 1.24 | 1.48 | 1.38 | 1.12 |
mRNA polyadenylation | 16 | 1.4 | 1.12 | 1.26 | 1.13 | 1.32 | 1.72 | 1.2 |
adenosine to inosine editing | 1 | 1.13 | 1.14 | 1.55 | 1.01 | 1.4 | 2.0 | 1.26 |
tRNA splicing, via endonucleolytic cleavage and ligation | 3 | 1.93 | 1.15 | 1.42 | 1.2 | 1.36 | 1.44 | 1.34 |
transcription from mitochondrial promoter | 3 | 1.29 | 1.23 | 1.41 | 1.12 | 1.47 | 1.73 | -1.1 |
snRNA export from nucleus | 2 | 1.9 | 1.18 | 1.33 | 1.29 | 1.62 | 1.23 | 1.13 |
tRNA export from nucleus | 1 | 1.48 | 1.1 | 1.33 | 1.32 | 1.54 | -1.18 | -1.04 |
translational termination | 6 | 1.2 | 1.18 | 1.21 | 1.16 | 1.16 | 1.51 | 1.06 |
aspartyl-tRNA aminoacylation | 1 | -1.97 | 1.61 | 1.28 | -1.18 | 1.45 | -1.88 | 1.38 |
cysteinyl-tRNA aminoacylation | 2 | -1.01 | 1.37 | 1.43 | 1.08 | 1.22 | 1.24 | 1.76 |
glutamyl-tRNA aminoacylation | 2 | 1.05 | 1.23 | 1.54 | -1.01 | 1.6 | 1.42 | 1.27 |
histidyl-tRNA aminoacylation | 1 | -1.32 | 1.37 | -1.07 | 1.31 | -1.14 | -1.74 | -1.19 |
isoleucyl-tRNA aminoacylation | 2 | 1.35 | 1.22 | 1.54 | 1.02 | 1.38 | 1.61 | 1.38 |
methionyl-tRNA aminoacylation | 2 | -1.59 | 1.18 | 1.28 | 1.38 | 1.17 | -1.27 | -1.03 |
threonyl-tRNA aminoacylation | 2 | -1.65 | 1.24 | 1.06 | 1.13 | -1.08 | -1.17 | 1.02 |
valyl-tRNA aminoacylation | 2 | -1.62 | 1.31 | 1.29 | 1.15 | 1.04 | -1.25 | 1.17 |
regulation of translational initiation | 10 | 1.76 | -1.0 | 1.08 | -1.04 | 1.23 | 1.53 | 1.27 |
regulation of translational initiation by iron | 2 | 1.36 | 1.24 | 1.32 | -1.06 | 1.1 | 1.69 | 1.16 |
regulation of translational elongation | 3 | 1.5 | 1.19 | 1.07 | 1.08 | 1.04 | 1.01 | 1.17 |
regulation of translational termination | 1 | 1.71 | 1.01 | 1.01 | -1.13 | 1.21 | 1.32 | 1.15 |
translational readthrough | 2 | 1.54 | 1.17 | 1.08 | 1.41 | 1.45 | -1.1 | -1.08 |
translational frameshifting | 1 | 1.71 | 1.01 | 1.01 | -1.13 | 1.21 | 1.32 | 1.15 |
signal peptide processing | 3 | 1.12 | -1.0 | 1.0 | -1.02 | -1.02 | -1.01 | 1.75 |
negative regulation of protein kinase activity | 12 | 1.53 | 1.14 | 1.46 | 1.09 | 1.41 | 1.69 | 1.32 |
N-terminal protein amino acid acetylation | 1 | -1.5 | 1.47 | 2.65 | 1.15 | 1.31 | -1.14 | -1.06 |
C-terminal protein methylation | 1 | -2.13 | 1.18 | 1.09 | 1.41 | 1.8 | -1.71 | -1.76 |
protein demethylation | 7 | 1.18 | 1.25 | 1.72 | 1.13 | 1.59 | 1.68 | 1.3 |
protein N-linked glycosylation | 14 | 1.33 | 1.02 | 1.11 | 1.03 | 1.13 | 1.55 | 1.26 |
N-glycan processing | 1 | 3.13 | 1.28 | 1.73 | 1.05 | 1.33 | 2.12 | 2.37 |
N-terminal protein lipidation | 2 | -1.18 | 1.31 | 1.73 | 1.36 | 1.77 | -1.01 | -1.01 |
N-terminal protein myristoylation | 1 | -1.49 | 1.29 | 1.71 | 1.24 | 1.7 | 1.05 | 1.0 |
N-terminal protein palmitoylation | 1 | 1.07 | 1.32 | 1.75 | 1.48 | 1.85 | -1.07 | -1.03 |
protein geranylgeranylation | 1 | 1.07 | 1.22 | 1.65 | 1.13 | 1.53 | -1.02 | -1.05 |
proteolysis | 624 | -1.68 | -1.23 | -1.28 | -1.03 | -1.1 | -1.65 | -1.4 |
membrane protein ectodomain proteolysis | 2 | -1.1 | 1.22 | 1.43 | 1.31 | 1.8 | -1.31 | 1.17 |
protein monoubiquitination | 1 | -1.01 | -1.28 | 2.49 | -1.24 | 1.59 | -1.44 | -1.52 |
misfolded or incompletely synthesized protein catabolic process | 1 | 2.66 | -1.19 | -1.04 | 1.2 | -1.17 | 1.37 | 1.41 |
glycoprotein catabolic process | 1 | -1.09 | 1.27 | 1.39 | 1.28 | 1.54 | -1.1 | 1.18 |
protein deglycosylation | 1 | 3.0 | -1.25 | -1.04 | 1.43 | 1.17 | 2.32 | 1.34 |
alanine metabolic process | 1 | 1.7 | 1.2 | 1.13 | 1.08 | -1.16 | -1.08 | 1.29 |
alanine biosynthetic process | 1 | 1.7 | 1.2 | 1.13 | 1.08 | -1.16 | -1.08 | 1.29 |
arginine metabolic process | 5 | -5.16 | 1.27 | -5.44 | 1.2 | 1.07 | -3.1 | -1.21 |
arginine biosynthetic process | 2 | -22.15 | 1.64 | -12.84 | 1.4 | 1.07 | -7.77 | -1.97 |
arginine catabolic process | 2 | -3.2 | -1.06 | -5.13 | -1.12 | -1.07 | -1.58 | 1.05 |
aspartate metabolic process | 2 | 1.83 | 1.18 | -1.32 | -1.0 | 1.19 | 1.57 | 1.14 |
cysteine metabolic process | 3 | 1.38 | 1.11 | 1.22 | -1.23 | -2.05 | -1.02 | 1.55 |
cysteine biosynthetic process from serine | 1 | 1.25 | 1.1 | 1.48 | -1.98 | -7.11 | -1.17 | 2.59 |
glutamate metabolic process | 10 | -1.06 | -1.22 | -1.57 | -1.37 | 1.12 | 1.73 | -1.05 |
glutamate biosynthetic process | 5 | 1.59 | -1.31 | -1.43 | -1.5 | -1.34 | 2.96 | 1.23 |
glutamate catabolic process | 4 | -1.09 | -1.24 | 1.09 | -1.34 | 1.82 | 1.75 | -1.68 |
glutamine metabolic process | 5 | -1.72 | -1.12 | -1.2 | -1.13 | 1.54 | -1.57 | -3.03 |
glutamine biosynthetic process | 2 | 1.91 | -1.99 | 2.01 | -1.44 | 1.52 | -1.73 | -1.25 |
glutamine catabolic process | 1 | -1.12 | 1.14 | 1.63 | 1.21 | 1.33 | 1.0 | 1.05 |
glycine metabolic process | 9 | 1.41 | 1.01 | 1.25 | -1.01 | -1.01 | 1.77 | -1.06 |
glycine biosynthetic process | 1 | 2.25 | -1.1 | -1.03 | 1.28 | 1.09 | 2.14 | -1.24 |
glycine catabolic process | 6 | 1.21 | 1.07 | 1.39 | -1.04 | -1.02 | 1.86 | -1.02 |
leucine metabolic process | 4 | 1.15 | 1.54 | 1.31 | 1.24 | 1.31 | 1.45 | 1.1 |
lysine metabolic process | 1 | -1.51 | -1.6 | -1.42 | 1.8 | -1.74 | 2.0 | -2.55 |
lysine catabolic process | 1 | -1.51 | -1.6 | -1.42 | 1.8 | -1.74 | 2.0 | -2.55 |
methionine metabolic process | 6 | 1.26 | -1.05 | -1.1 | -1.03 | -1.11 | 1.66 | -1.23 |
S-adenosylmethionine biosynthetic process | 1 | 1.6 | 1.05 | 1.23 | -1.23 | 1.41 | 1.78 | 1.98 |
L-phenylalanine metabolic process | 4 | 1.52 | -1.14 | -1.01 | -1.01 | -1.02 | 2.14 | -1.13 |
L-phenylalanine catabolic process | 4 | 1.52 | -1.14 | -1.01 | -1.01 | -1.02 | 2.14 | -1.13 |
proline metabolic process | 7 | -1.43 | -1.33 | -1.79 | -1.62 | -1.41 | 1.63 | 1.05 |
proline biosynthetic process | 4 | -1.95 | -1.03 | -1.89 | -1.37 | -1.23 | 1.12 | 1.21 |
proline catabolic process | 2 | 1.19 | -2.55 | -2.04 | -2.77 | -1.87 | 5.01 | -1.07 |
L-serine metabolic process | 5 | 2.33 | 1.11 | -1.22 | 1.0 | -1.34 | 1.61 | 1.43 |
L-serine biosynthetic process | 4 | 2.73 | 1.12 | -1.41 | 1.19 | 1.13 | 1.89 | 1.23 |
tryptophan catabolic process | 2 | 1.18 | -1.21 | -1.17 | -1.24 | -1.21 | 1.62 | -1.18 |
tyrosine metabolic process | 8 | 1.53 | -1.29 | -1.23 | -1.14 | -1.34 | 1.56 | 1.15 |
betaine biosynthetic process | 1 | 1.3 | -1.08 | -1.07 | -1.13 | -1.19 | 1.96 | -1.06 |
ethanolamine metabolic process | 1 | 1.07 | -1.05 | 2.34 | 1.23 | 1.45 | 3.99 | 1.1 |
acetylcholine catabolic process | 1 | 2.27 | 1.23 | -5.17 | -1.59 | -2.2 | -9.9 | 9.42 |
melanin metabolic process | 16 | 2.27 | -1.2 | -1.16 | -1.18 | 1.1 | 1.65 | 1.32 |
melanin biosynthetic process from tyrosine | 4 | 1.82 | -1.08 | -1.09 | -1.03 | -1.18 | 1.82 | -1.13 |
catecholamine metabolic process | 9 | -1.02 | -1.18 | -1.26 | -1.16 | -1.28 | -1.1 | 1.52 |
dopamine biosynthetic process from tyrosine | 1 | 1.23 | -4.96 | -5.74 | -3.75 | -6.41 | -1.0 | 6.11 |
indolalkylamine metabolic process | 8 | -1.18 | -1.2 | -1.54 | -1.13 | -1.45 | -1.17 | 1.22 |
serotonin biosynthetic process from tryptophan | 2 | 1.67 | -2.04 | -2.31 | -1.94 | -2.17 | 1.48 | 3.91 |
activation of tryptophan 5-monooxygenase activity | 1 | 2.28 | 1.19 | 1.07 | -1.0 | 1.37 | 2.2 | 2.5 |
ornithine metabolic process | 3 | -2.2 | 1.14 | -2.13 | 1.11 | -1.02 | -1.24 | -1.28 |
polyamine biosynthetic process | 5 | 1.03 | -1.1 | -1.08 | 1.04 | -1.04 | 1.59 | -1.28 |
spermine biosynthetic process | 2 | 1.12 | 1.21 | 1.31 | 1.22 | 1.2 | 1.92 | 1.01 |
NLS-bearing substrate import into nucleus | 7 | -1.09 | 1.31 | 1.37 | 1.28 | 1.56 | 1.0 | 1.17 |
protein export from nucleus | 5 | 1.19 | 1.11 | 2.28 | 1.15 | 1.72 | 1.71 | 1.32 |
cotranslational protein targeting to membrane | 16 | -1.27 | 1.37 | -1.06 | 1.05 | -1.21 | -1.6 | 1.25 |
SRP-dependent cotranslational protein targeting to membrane | 15 | -1.21 | 1.37 | -1.05 | 1.04 | -1.19 | -1.54 | 1.26 |
SRP-dependent cotranslational protein targeting to membrane, translocation | 5 | -1.62 | 1.28 | -1.17 | -1.01 | -1.28 | -1.9 | 1.13 |
SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition | 1 | -1.09 | 1.62 | 1.41 | 1.12 | 1.35 | 1.19 | 1.81 |
protein retention in ER lumen | 3 | -1.9 | 1.28 | -1.09 | 1.08 | -1.19 | -2.08 | 1.34 |
protein targeting to lysosome | 3 | 1.19 | 1.18 | 1.82 | 1.21 | 1.4 | 1.29 | 1.24 |
protein targeting to vacuole | 4 | 1.47 | 1.26 | 2.02 | 1.17 | 1.52 | 1.6 | 1.47 |
fatty acid biosynthetic process | 25 | 1.1 | -1.38 | -1.52 | -1.26 | -1.29 | 1.04 | 1.14 |
fatty acid beta-oxidation | 12 | -1.2 | 1.1 | -1.58 | 1.06 | 1.17 | -2.29 | -1.36 |
unsaturated fatty acid biosynthetic process | 1 | -1.74 | 1.11 | -2.01 | 1.51 | 1.27 | -1.87 | -1.55 |
acyl-CoA metabolic process | 6 | 2.01 | 1.03 | 1.27 | 1.12 | 1.42 | 1.33 | 1.06 |
neutral lipid metabolic process | 10 | 1.74 | -1.01 | 1.02 | -1.04 | 1.58 | -1.11 | -1.1 |
acylglycerol metabolic process | 10 | 1.74 | -1.01 | 1.02 | -1.04 | 1.58 | -1.11 | -1.1 |
triglyceride metabolic process | 7 | 1.7 | 1.03 | -1.06 | -1.02 | 1.5 | 1.09 | -1.06 |
triglyceride mobilization | 1 | -2.11 | 1.69 | -1.72 | -1.16 | 2.47 | -2.75 | -1.82 |
membrane lipid metabolic process | 28 | -2.18 | -1.19 | -1.19 | 1.18 | 1.02 | -2.06 | -1.41 |
phosphatidylethanolamine biosynthetic process | 1 | 1.07 | -1.05 | 2.34 | 1.23 | 1.45 | 3.99 | 1.1 |
diacylglycerol biosynthetic process | 2 | 4.42 | -1.06 | 2.12 | -1.4 | 1.56 | 1.46 | 1.74 |
phosphatidylglycerol biosynthetic process | 1 | -3.36 | 1.4 | 1.32 | 1.25 | 1.35 | -2.25 | 1.21 |
phosphatidylcholine biosynthetic process | 1 | -1.0 | -1.38 | 1.09 | 1.05 | 1.26 | -1.4 | 2.06 |
phosphatidylserine metabolic process | 1 | 1.61 | 1.37 | 2.22 | 1.0 | 1.13 | 1.67 | 1.83 |
phosphatidylserine biosynthetic process | 1 | 1.61 | 1.37 | 2.22 | 1.0 | 1.13 | 1.67 | 1.83 |
glycolipid metabolic process | 8 | 1.02 | 1.23 | 1.09 | 1.02 | 1.05 | -1.13 | 1.74 |
sphingolipid metabolic process | 24 | -2.32 | -1.33 | -1.28 | 1.19 | 1.03 | -2.16 | -1.6 |
ceramide metabolic process | 7 | -1.82 | -1.06 | 1.22 | 1.15 | 1.12 | -2.11 | -1.7 |
sphingomyelin metabolic process | 5 | -5.26 | -3.33 | -4.18 | 1.39 | -1.08 | -3.6 | -4.11 |
sphingomyelin catabolic process | 3 | -14.19 | -8.88 | -14.23 | 1.69 | -1.38 | -9.59 | -10.93 |
sphingomyelin biosynthetic process | 1 | -1.01 | 1.47 | 1.74 | -1.23 | 1.22 | 1.11 | 1.04 |
glycosphingolipid metabolic process | 5 | 1.35 | 1.03 | 1.0 | 1.01 | 1.04 | 1.17 | 1.95 |
glycosphingolipid biosynthetic process | 4 | 1.47 | 1.01 | -1.03 | -1.08 | 1.02 | 1.2 | 2.34 |
icosanoid metabolic process | 1 | -1.74 | 1.11 | -2.01 | 1.51 | 1.27 | -1.87 | -1.55 |
leukotriene metabolic process | 1 | -1.74 | 1.11 | -2.01 | 1.51 | 1.27 | -1.87 | -1.55 |
cholesterol biosynthetic process | 1 | 2.16 | -1.1 | 1.03 | -1.13 | 1.06 | 2.2 | 1.18 |
cholesterol catabolic process | 1 | -1.19 | 1.24 | 1.2 | 1.43 | 1.53 | -1.12 | -1.13 |
sesquiterpenoid metabolic process | 6 | -1.16 | -1.26 | -1.56 | -1.5 | -1.43 | -2.35 | 1.61 |
juvenile hormone metabolic process | 6 | -1.16 | -1.26 | -1.56 | -1.5 | -1.43 | -2.35 | 1.61 |
juvenile hormone biosynthetic process | 2 | 1.77 | -2.92 | -3.1 | -3.09 | -1.69 | -1.43 | 2.62 |
juvenile hormone catabolic process | 4 | -1.67 | 1.21 | -1.1 | -1.05 | -1.31 | -3.02 | 1.26 |
terpenoid metabolic process | 11 | -1.32 | -1.26 | -1.61 | -1.13 | -1.21 | -1.86 | 1.01 |
pteridine biosynthetic process | 5 | 2.4 | -1.22 | -1.26 | -1.24 | -1.16 | -1.04 | 1.7 |
tetrahydrobiopterin biosynthetic process | 4 | 7.84 | -1.48 | -1.41 | -1.58 | -1.23 | 1.76 | 2.48 |
one-carbon metabolic process | 15 | -1.73 | -1.28 | 1.21 | -1.29 | 1.06 | 1.32 | -1.1 |
oxidoreduction coenzyme metabolic process | 16 | 1.6 | 1.17 | -1.26 | 1.03 | 1.09 | 1.19 | 1.2 |
NADH metabolic process | 1 | -1.32 | -1.9 | 1.3 | -2.14 | 3.35 | 4.87 | -4.48 |
NADP metabolic process | 7 | 2.13 | 1.17 | -1.85 | 1.03 | -1.09 | 1.03 | 1.53 |
NADPH regeneration | 7 | 2.13 | 1.17 | -1.85 | 1.03 | -1.09 | 1.03 | 1.53 |
lipoamide metabolic process | 1 | -1.4 | -1.14 | 2.27 | -1.25 | -1.48 | 1.94 | -1.5 |
glutathione biosynthetic process | 3 | -2.99 | 1.44 | -1.36 | 1.22 | -1.32 | -2.2 | 1.15 |
ATP biosynthetic process | 25 | 1.34 | 1.04 | 1.24 | -1.05 | 1.09 | 1.66 | -1.1 |
folic acid-containing compound metabolic process | 8 | 1.68 | -1.27 | -1.29 | -1.11 | -1.33 | 1.27 | 1.0 |
vitamin metabolic process | 11 | 1.53 | 1.22 | -1.23 | -1.04 | -1.18 | 1.35 | 1.13 |
water-soluble vitamin metabolic process | 7 | 1.81 | 1.34 | -1.5 | -1.06 | -1.3 | 1.43 | 1.2 |
riboflavin metabolic process | 2 | 1.78 | 2.05 | -2.11 | -2.16 | -2.52 | 2.14 | 1.44 |
thiamine metabolic process | 1 | 1.06 | 1.62 | -1.26 | 1.22 | -1.14 | -1.11 | 1.12 |
protoporphyrinogen IX biosynthetic process | 1 | 1.62 | 1.26 | 1.09 | -1.07 | 1.01 | 1.21 | 1.32 |
heme a biosynthetic process | 1 | -1.08 | 1.29 | 1.99 | 1.12 | 1.3 | 1.57 | -1.3 |
porphyrin-containing compound catabolic process | 1 | 2.0 | 1.05 | 2.09 | 1.06 | 1.46 | 2.34 | 1.12 |
heme oxidation | 1 | 2.0 | 1.05 | 2.09 | 1.06 | 1.46 | 2.34 | 1.12 |
xenobiotic metabolic process | 10 | 1.1 | -1.02 | -1.79 | -1.06 | -1.28 | -1.46 | 1.06 |
response to insecticide | 16 | 1.05 | 1.09 | -1.54 | -1.14 | -1.27 | -1.41 | 1.29 |
calcium ion transport | 24 | 1.54 | -1.04 | 1.07 | -1.11 | 1.19 | 1.63 | 1.19 |
phosphate ion transport | 10 | -1.16 | -1.04 | -1.52 | -1.15 | 1.01 | 2.17 | -1.68 |
chloride transport | 6 | 1.12 | 1.13 | -1.09 | 1.06 | 1.34 | 1.82 | 1.32 |
water transport | 3 | -1.65 | 1.03 | -1.57 | 1.34 | -1.36 | -2.48 | 1.11 |
dicarboxylic acid transport | 8 | 1.09 | -1.04 | -1.41 | -1.66 | -1.35 | 1.44 | 1.09 |
serotonin transport | 1 | -1.06 | -1.11 | -1.0 | -1.08 | -1.15 | 3.37 | -1.04 |
alpha-ketoglutarate transport | 3 | -1.11 | -1.06 | 1.14 | -1.03 | -1.15 | 1.61 | -1.21 |
malate transport | 5 | -1.06 | -1.22 | 1.26 | -1.12 | 1.12 | 2.23 | -1.26 |
mitochondrial citrate transport | 1 | -1.29 | 1.86 | -1.38 | -1.29 | -2.25 | 1.02 | -1.13 |
acyl carnitine transport | 2 | 1.34 | 1.32 | -1.91 | 1.22 | 1.14 | -1.7 | -1.23 |
aspartate transport | 1 | 2.24 | 1.81 | -38.59 | -31.15 | -18.58 | -3.21 | 4.55 |
L-glutamate transport | 4 | -2.92 | -1.1 | -4.98 | -1.98 | -1.32 | -2.35 | -3.75 |
mitochondrial calcium ion transport | 1 | 1.01 | 1.3 | 1.51 | 1.08 | 2.35 | 4.41 | 1.77 |
drug transmembrane transport | 1 | -10.37 | 1.6 | -11.08 | 1.04 | 2.2 | -3.48 | 1.28 |
oligopeptide transport | 3 | 1.69 | -1.17 | -1.51 | -1.15 | -1.07 | 1.17 | 1.2 |
amino acid transport | 39 | -1.51 | -1.14 | -1.83 | -1.24 | 1.0 | -1.08 | -1.16 |
glutamine transport | 1 | -3.47 | -4.26 | 1.06 | 2.44 | 2.17 | -3.37 | -7.09 |
lipid transport | 28 | -2.26 | -1.6 | -1.93 | -1.01 | -1.22 | -1.56 | -1.89 |
cellular calcium ion homeostasis | 10 | 1.86 | -1.02 | 1.36 | -1.1 | -1.04 | 1.64 | 1.18 |
cellular copper ion homeostasis | 2 | -1.26 | 1.35 | 2.1 | 1.13 | 1.14 | 1.39 | 1.07 |
cellular zinc ion homeostasis | 1 | -1.15 | 1.5 | 3.36 | 1.09 | -1.02 | -1.02 | -1.03 |
cell volume homeostasis | 2 | 1.92 | 1.08 | -1.06 | -1.08 | 2.11 | 2.25 | 1.09 |
regulation of pH | 9 | -1.27 | 1.25 | 1.91 | -1.01 | 1.19 | 1.86 | 1.45 |
retrograde vesicle-mediated transport, Golgi to ER | 8 | -1.71 | 1.25 | -1.07 | 1.15 | -1.15 | -1.33 | 1.34 |
intra-Golgi vesicle-mediated transport | 18 | -1.13 | 1.2 | 1.21 | 1.08 | 1.18 | 1.32 | 1.58 |
Golgi to vacuole transport | 1 | 1.54 | 1.27 | 1.89 | 1.07 | 1.6 | 1.7 | 1.58 |
receptor-mediated endocytosis | 11 | 1.09 | 1.13 | 1.29 | 1.01 | 1.19 | 1.55 | 1.26 |
anti-apoptosis | 18 | 1.77 | 1.02 | 1.32 | -1.0 | 1.46 | 1.51 | 1.52 |
cellular component disassembly involved in apoptotic process | 4 | -1.16 | 1.19 | 1.65 | 1.21 | 1.51 | -1.05 | -1.11 |
cleavage of lamin | 1 | -11.86 | 1.52 | 2.29 | 1.45 | 1.79 | -4.95 | -7.15 |
cleavage of cytoskeletal proteins involved in apoptosis | 1 | -11.86 | 1.52 | 2.29 | 1.45 | 1.79 | -4.95 | -7.15 |
regulation of muscle contraction | 5 | 2.39 | -1.02 | -2.05 | -2.54 | -2.17 | 1.16 | 1.24 |
striated muscle contraction | 4 | -1.17 | -1.12 | -1.49 | -1.32 | -1.09 | 1.16 | 1.78 |
regulation of striated muscle contraction | 2 | 1.48 | 1.35 | -6.16 | -5.66 | -4.42 | -1.74 | 2.14 |
response to mechanical stimulus | 14 | 1.05 | -1.27 | 1.01 | -1.36 | -1.07 | 1.88 | 1.17 |
pattern orientation | 1 | 1.15 | 1.52 | 1.62 | 1.11 | 1.74 | 1.53 | 2.02 |
positive regulation of antibacterial peptide biosynthetic process | 17 | 1.54 | -1.16 | -1.04 | -1.14 | 1.02 | 1.29 | 1.37 |
positive regulation of biosynthetic process of antibacterial peptides active against Gram-negative bacteria | 5 | 2.54 | -1.22 | -1.03 | -1.31 | -1.06 | 2.04 | 1.48 |
positive regulation of biosynthetic process of antibacterial peptides active against Gram-positive bacteria | 4 | 1.05 | -1.9 | -2.24 | -1.85 | -1.9 | -1.18 | 1.68 |
positive regulation of antifungal peptide biosynthetic process | 6 | 2.45 | -1.42 | -1.16 | -1.01 | -1.05 | 1.77 | 1.2 |
cellular defense response | 1 | 1.57 | 1.3 | 1.87 | 1.1 | 1.6 | 2.04 | 2.1 |
hyperosmotic response | 1 | 1.22 | 1.33 | 2.18 | 1.07 | 1.72 | 2.05 | 1.61 |
response to lipid hydroperoxide | 1 | 2.0 | -1.09 | -1.07 | 1.14 | 1.47 | 1.02 | -1.28 |
ER overload response | 2 | -1.22 | 1.43 | 1.56 | 1.09 | 1.42 | -1.17 | 1.79 |
nuclear pore organization | 1 | 1.8 | 1.61 | 2.39 | 1.2 | 2.33 | 2.16 | 2.46 |
nucleolus organization | 3 | 1.16 | 1.19 | 1.66 | 1.24 | 2.3 | 1.1 | 1.42 |
plasma membrane organization | 12 | 1.23 | 1.13 | 1.5 | 1.02 | 1.84 | 1.37 | 1.27 |
cytoskeletal anchoring at plasma membrane | 17 | 1.37 | 1.1 | 1.43 | 1.03 | 1.41 | 1.51 | 1.32 |
microtubule nucleation | 7 | 1.67 | 1.03 | 1.42 | 1.09 | 1.45 | 1.62 | 1.17 |
negative regulation of microtubule depolymerization | 15 | 1.06 | 1.15 | 1.48 | 1.04 | 1.41 | 1.59 | 1.26 |
endoplasmic reticulum organization | 7 | 1.12 | 1.24 | 1.29 | 1.1 | 1.28 | 1.04 | 1.52 |
peroxisome organization | 15 | 1.58 | 1.07 | -1.39 | 1.25 | 1.36 | -1.44 | -1.19 |
vacuolar transport | 17 | 1.14 | 1.17 | 1.78 | 1.13 | 1.5 | 1.47 | 1.29 |
vacuolar acidification | 4 | -2.16 | 1.36 | 2.14 | -1.07 | 1.21 | 2.24 | 1.25 |
lysosomal transport | 13 | -1.01 | 1.15 | 1.71 | 1.13 | 1.47 | 1.31 | 1.22 |
cell-cell junction assembly | 36 | 1.91 | -1.1 | 1.31 | -1.15 | 1.22 | 2.16 | 1.42 |
cell-substrate junction assembly | 1 | -1.1 | -1.15 | -1.07 | -1.18 | 1.52 | 1.28 | 1.24 |
cell cycle arrest | 8 | 1.45 | 1.2 | 1.34 | 1.1 | 1.36 | 1.5 | 1.38 |
spindle assembly involved in male meiosis | 3 | -1.71 | 1.36 | 1.08 | 1.16 | 1.08 | -1.71 | 1.01 |
spindle assembly involved in male meiosis I | 1 | 1.11 | 1.51 | 1.01 | 1.21 | 1.06 | -1.41 | 1.26 |
mitotic sister chromatid cohesion | 5 | 1.6 | 1.06 | 1.64 | 1.1 | 1.59 | 1.67 | 1.28 |
regulation of S phase of mitotic cell cycle | 16 | 1.38 | 1.18 | 1.34 | 1.13 | 1.4 | 1.63 | 1.43 |
optokinetic behavior | 2 | 1.16 | 1.09 | 1.72 | 1.19 | 1.37 | 1.2 | 2.11 |
cytokinesis after meiosis I | 8 | 1.52 | -1.23 | 1.02 | -1.47 | 1.08 | 1.67 | 1.38 |
cytokinesis after meiosis II | 7 | 1.71 | -1.31 | -1.08 | -1.6 | 1.08 | 2.04 | 1.46 |
male meiosis cytokinesis | 14 | 1.82 | -1.04 | 1.11 | -1.11 | 1.39 | 1.32 | 1.33 |
meiotic prophase I | 1 | 1.5 | 1.02 | 1.68 | -1.05 | 1.78 | 1.86 | 1.49 |
meiotic metaphase I | 1 | 1.38 | 1.21 | 1.33 | 1.18 | 1.64 | 1.12 | 1.06 |
homophilic cell adhesion | 27 | 1.7 | -1.16 | -1.1 | -1.17 | 1.12 | 1.92 | 1.39 |
negative regulation of cell adhesion | 9 | 1.95 | 1.17 | 1.32 | 1.03 | 1.28 | 1.88 | 1.51 |
signal complex assembly | 1 | 1.01 | 1.19 | 1.87 | 1.24 | 1.92 | 1.43 | 1.32 |
transforming growth factor beta binding | 1 | -2.53 | 1.23 | -1.01 | 1.28 | 2.46 | 1.22 | 1.76 |
transforming growth factor beta receptor complex assembly | 1 | -2.53 | 1.23 | -1.01 | 1.28 | 2.46 | 1.22 | 1.76 |
transmembrane receptor protein tyrosine phosphatase signaling pathway | 1 | 1.65 | 1.02 | 2.09 | -1.05 | 1.83 | 4.08 | 1.95 |
elevation of cytosolic calcium ion concentration | 3 | 1.46 | 1.16 | 1.52 | -1.0 | 1.18 | 1.77 | 1.54 |
activation of protein kinase C activity by G-protein coupled receptor protein signaling pathway | 8 | 1.65 | 1.05 | -1.03 | -1.02 | -1.04 | 1.17 | 1.24 |
tachykinin receptor signaling pathway | 5 | -1.04 | -1.19 | 1.08 | -1.24 | -1.02 | 1.95 | 1.43 |
neuropeptide signaling pathway | 38 | -1.86 | -1.39 | -1.2 | -1.15 | -1.16 | -1.83 | -1.26 |
Notch receptor processing | 4 | -1.0 | 1.17 | 1.21 | 1.25 | 1.56 | 1.22 | 1.41 |
patched ligand maturation | 1 | 1.07 | 1.32 | 1.75 | 1.48 | 1.85 | -1.07 | -1.03 |
signal transduction downstream of smoothened | 5 | 1.03 | 1.18 | 1.56 | 1.12 | 1.42 | 1.4 | 1.07 |
positive regulation of hh target transcription factor activity | 5 | 1.03 | 1.18 | 1.56 | 1.12 | 1.42 | 1.4 | 1.07 |
integrin-mediated signaling pathway | 4 | -1.54 | 1.07 | 1.65 | 1.1 | 1.77 | -1.22 | 1.11 |
I-kappaB kinase/NF-kappaB cascade | 2 | 1.26 | 1.28 | 1.33 | 1.08 | 1.48 | 1.61 | 1.39 |
JNK cascade | 25 | 1.0 | 1.14 | 1.47 | 1.1 | 1.5 | 1.24 | 1.42 |
activation of JNKK activity | 2 | 1.23 | 1.27 | 1.56 | 1.2 | 1.54 | 1.23 | 1.3 |
activation of JUN kinase activity | 2 | -1.08 | 1.31 | 1.72 | 1.2 | 1.5 | 1.32 | 1.54 |
tyrosine phosphorylation of STAT protein | 1 | 1.57 | 1.3 | 1.87 | 1.1 | 1.6 | 2.04 | 2.1 |
STAT protein import into nucleus | 1 | 1.57 | 1.3 | 1.87 | 1.1 | 1.6 | 2.04 | 2.1 |
Ras protein signal transduction | 25 | 1.08 | 1.28 | 1.57 | 1.08 | 1.47 | 1.22 | 1.49 |
Rho protein signal transduction | 4 | -1.15 | 1.27 | 1.54 | 1.2 | 1.45 | 1.01 | 1.39 |
neuron-neuron synaptic transmission | 5 | 1.1 | -1.05 | -1.09 | -1.15 | 1.01 | 2.0 | 1.04 |
synaptic transmission, cholinergic | 1 | 2.27 | 1.23 | -5.17 | -1.59 | -2.2 | -9.9 | 9.42 |
ensheathment of neurons | 6 | 1.77 | -1.07 | 1.38 | -1.13 | 1.24 | 3.0 | 1.46 |
pole cell fate determination | 3 | 2.8 | 1.18 | 2.04 | 1.19 | 1.51 | 2.12 | 1.41 |
primary spermatocyte growth | 5 | 2.0 | 1.25 | 1.67 | 1.27 | 1.92 | 1.51 | 1.27 |
growth of a germarium-derived egg chamber | 5 | 1.5 | 1.13 | 1.67 | 1.04 | 1.5 | 1.59 | 1.41 |
vitellogenesis | 7 | 1.4 | -3.65 | -4.11 | -4.07 | -1.34 | 2.21 | 1.12 |
ovarian follicle cell-cell adhesion | 3 | -1.5 | 1.41 | 1.37 | 1.22 | 1.72 | -1.12 | -1.09 |
nurse cell nucleus anchoring | 1 | -1.33 | 1.57 | 2.09 | 1.17 | 1.77 | 1.11 | 1.58 |
eggshell chorion gene amplification | 17 | 1.11 | 1.21 | 1.43 | 1.19 | 1.52 | 1.14 | 1.14 |
oocyte dorsal/ventral axis specification | 34 | 1.43 | 1.04 | 1.13 | 1.01 | 1.1 | 1.5 | 1.28 |
maternal specification of dorsal/ventral axis, oocyte, germ-line encoded | 7 | 1.96 | -1.07 | -1.01 | -1.08 | 1.03 | 2.21 | 1.39 |
pole plasm protein localization | 10 | 1.29 | 1.15 | 1.44 | 1.11 | 1.37 | 1.64 | 1.23 |
negative regulation of oskar mRNA translation | 8 | 1.19 | -1.01 | 1.28 | -1.09 | 1.13 | 1.88 | 1.01 |
regulation of preblastoderm mitotic cell cycle | 1 | 2.87 | 1.19 | 1.15 | 1.16 | 1.39 | 3.16 | 1.43 |
zygotic specification of dorsal/ventral axis | 5 | 1.69 | 1.14 | 1.51 | 1.04 | 1.21 | 1.21 | 1.19 |
zygotic determination of anterior/posterior axis, embryo | 31 | 1.57 | -1.1 | 1.04 | -1.14 | 1.04 | 1.27 | 1.27 |
anterior region determination | 3 | 1.62 | -1.05 | 1.0 | -1.14 | -1.1 | 1.06 | -1.02 |
posterior abdomen determination | 1 | 2.58 | 1.01 | 1.0 | 1.14 | -1.0 | -1.14 | 1.0 |
determination of left/right symmetry | 4 | -3.48 | 1.34 | 1.25 | 1.01 | 1.41 | -1.67 | 1.12 |
ventral furrow formation | 13 | 1.35 | 1.11 | 1.28 | 1.08 | 1.5 | 1.38 | 1.28 |
posterior midgut invagination | 4 | 1.75 | 1.13 | 1.9 | 1.13 | 1.88 | 1.93 | 1.72 |
anterior midgut invagination | 3 | 1.4 | 1.11 | 1.46 | 1.17 | 1.72 | 1.88 | 1.31 |
germ-band extension | 8 | -1.08 | -1.25 | 1.17 | 1.08 | 1.55 | 1.32 | -1.22 |
amnioserosa formation | 5 | 1.56 | -1.06 | 1.14 | -1.19 | -1.08 | -1.04 | 1.05 |
specification of segmental identity, antennal segment | 3 | 1.59 | -1.13 | 1.32 | 1.09 | -1.18 | -1.05 | -1.16 |
specification of segmental identity, thorax | 2 | 1.34 | 1.12 | 1.12 | 1.65 | -1.14 | 1.05 | -1.1 |
germ-band shortening | 18 | 1.2 | 1.11 | 1.38 | 1.07 | 1.46 | 1.23 | 1.55 |
initiation of dorsal closure | 17 | 1.16 | 1.17 | 1.59 | 1.07 | 1.56 | 1.2 | 1.36 |
dorsal closure, leading edge cell fate determination | 3 | 1.0 | 1.08 | 1.89 | 1.0 | 1.21 | -1.44 | -1.04 |
dorsal closure, elongation of leading edge cells | 12 | 1.22 | 1.22 | 1.4 | 1.12 | 1.59 | 1.38 | 1.41 |
dorsal closure, spreading of leading edge cells | 4 | 1.03 | 1.07 | 2.59 | -1.02 | 1.79 | 1.38 | 1.66 |
suture of dorsal opening | 3 | -1.66 | 1.12 | 1.92 | -1.03 | 1.4 | -1.35 | 1.31 |
glial cell fate determination | 3 | 1.44 | 1.3 | 1.68 | 1.12 | 1.63 | 1.5 | 1.59 |
negative regulation of neuroblast proliferation | 7 | -1.32 | 1.13 | 1.47 | 1.06 | 1.79 | 1.22 | 1.08 |
stomatogastric nervous system development | 3 | 1.52 | 1.02 | 1.2 | 1.12 | 1.56 | 1.54 | 1.47 |
open tracheal system development | 179 | 1.41 | 1.03 | 1.26 | -1.02 | 1.26 | 1.52 | 1.28 |
epithelial cell fate determination, open tracheal system | 5 | 1.83 | 1.1 | 1.52 | -1.02 | 1.42 | 1.21 | 1.34 |
epithelial cell migration, open tracheal system | 28 | 1.66 | -1.03 | 1.29 | -1.07 | 1.21 | 1.38 | 1.11 |
primary branching, open tracheal system | 14 | 1.41 | 1.06 | 1.72 | 1.04 | 1.34 | 1.6 | 1.2 |
secondary branching, open tracheal system | 4 | -1.26 | 1.18 | 1.54 | -1.02 | 1.25 | 1.45 | 1.01 |
terminal branching, open tracheal system | 10 | 1.25 | 1.17 | 1.56 | 1.07 | 1.46 | 1.37 | 1.13 |
salivary gland boundary specification | 12 | 1.24 | 1.02 | 1.3 | 1.14 | 1.55 | 1.11 | 1.19 |
larval salivary gland morphogenesis | 6 | -1.03 | 1.12 | 1.25 | 1.04 | 1.36 | 1.52 | 1.57 |
ectodermal digestive tract development | 5 | 1.46 | 1.11 | -1.0 | 1.02 | 1.62 | 1.8 | 1.33 |
dorsal/ventral lineage restriction, imaginal disc | 7 | 1.04 | 1.11 | 1.08 | 1.07 | 1.41 | 1.38 | 1.52 |
progression of morphogenetic furrow involved in compound eye morphogenesis | 8 | 1.62 | -1.01 | 1.33 | 1.05 | 1.35 | 1.15 | 1.12 |
regulation of rhodopsin gene expression | 2 | 1.63 | 1.26 | 1.37 | 1.04 | 1.38 | 1.48 | 1.42 |
wing disc proximal/distal pattern formation | 6 | 1.82 | -1.07 | 1.3 | 1.34 | 1.32 | 1.02 | -1.06 |
apposition of dorsal and ventral imaginal disc-derived wing surfaces | 17 | 1.92 | 1.04 | 1.15 | -1.07 | 1.24 | 1.93 | 1.28 |
haltere disc morphogenesis | 2 | 2.21 | -1.24 | 1.11 | 1.19 | -1.26 | -1.2 | -1.1 |
imaginal disc-derived genitalia development | 22 | 1.56 | 1.05 | 1.18 | 1.02 | 1.13 | 1.11 | 1.24 |
imaginal disc-derived male genitalia development | 20 | 1.63 | 1.05 | 1.2 | 1.02 | 1.16 | 1.13 | 1.28 |
analia development | 6 | -1.15 | -1.64 | -1.26 | 1.2 | 1.4 | -1.24 | -1.79 |
histoblast morphogenesis | 8 | -1.19 | 1.09 | 1.37 | 1.16 | 1.65 | -1.2 | 1.21 |
maintenance of imaginal histoblast diploidy | 1 | -10.7 | -1.04 | 2.18 | 1.33 | 2.43 | -8.45 | -1.16 |
endodermal cell fate determination | 1 | 8.12 | -1.58 | 1.44 | -1.54 | 1.01 | 1.69 | 1.21 |
anterior midgut development | 3 | -1.08 | 1.25 | 1.25 | -1.4 | 1.12 | 1.13 | 1.58 |
mesodermal cell fate determination | 5 | 1.66 | 1.11 | 1.13 | -1.01 | 1.25 | 1.53 | 1.29 |
larval heart development | 2 | 1.04 | -1.11 | 1.46 | -1.3 | -1.07 | -1.65 | 1.78 |
mesoderm migration involved in gastrulation | 10 | 1.62 | -1.05 | 1.42 | -1.16 | 1.22 | 2.32 | 1.08 |
hemocyte development | 5 | 1.5 | 1.11 | 1.52 | 1.05 | 1.28 | 1.12 | 1.43 |
larval visceral muscle development | 5 | 1.28 | -1.03 | 1.19 | -1.12 | 1.18 | 1.12 | 1.5 |
larval somatic muscle development | 8 | 1.66 | 1.08 | 1.35 | 1.03 | 1.17 | 1.3 | 1.22 |
adult somatic muscle development | 10 | 1.25 | 1.07 | 1.59 | 1.07 | 1.35 | 1.16 | 1.08 |
primary sex determination, germ-line | 4 | 1.82 | 1.02 | 1.1 | 1.07 | 1.07 | 1.73 | 1.13 |
regulation of ecdysteroid metabolic process | 1 | -1.55 | 1.2 | 1.21 | -1.19 | -1.12 | 1.05 | 1.03 |
regulation of ecdysteroid secretion | 1 | -1.14 | 1.41 | 1.3 | 1.24 | 1.17 | 1.85 | 1.43 |
regulation of juvenile hormone metabolic process | 2 | -8.29 | -1.83 | 1.21 | 1.4 | 1.08 | -7.35 | -3.84 |
regulation of juvenile hormone biosynthetic process | 2 | -8.29 |